Stagescancer.net Understanding Advanced Cancer Spread

Stagescancer.net – Prostate cancer is the second most common cancer among men in the United States, after skin cancer. When prostate cancer advances to stage 4 and spreads to the bones, it can significantly impact life expectancy. In this section, we will examine the factors that affect life expectancy for individuals with stage 4 prostate cancer that has spread to the bones. We will help readers gain an understanding of the impact of bone metastasis on life expectancy, explore treatment options, and discuss the importance of emotional support, lifestyle modifications, and building a supportive network for patients and their families.

Our goal is to provide informative and compassionate insights that support individuals through this challenging journey.

Understanding Stage 4 Prostate Cancer

Prostate cancer is a type of cancer that develops in the prostate gland, which is located below the bladder of men. When cancer cells grow and spread beyond the prostate gland, it is called stage 4 prostate cancer. Understanding this advanced stage of prostate cancer is critical in comprehending its impact on life expectancy.

Causes

While the exact causes of prostate cancer are not yet clear, research has identified several risk factors, including age, genetics, race, and lifestyle factors such as diet and exercise. Certain genetic mutations and changes in hormone levels may also contribute to prostate cancer.

Symptoms

Early-stage prostate cancer does not typically cause symptoms, which is why regular screening is essential in detecting the cancer. As the cancer progresses, symptoms such as difficulty urinating, blood in the urine or semen, bone pain, and erectile dysfunction may occur.

Staging Process

The staging process determines the extent of cancer and how far it has spread. Tests such as biopsies, bone scans, CT scans, MRIs, and blood tests may be used to stage prostate cancer. The four stages of prostate cancer are:

Stage	Description
Stage I	In this stage, prostate cancer is small, non-invasive, and located only in the prostate gland.
Stage II	This stage involves a larger tumor that is still confined to the prostate gland.
Stage III	In stage III, the cancer has grown outside the prostate gland and may have invaded nearby tissues or organs.
Stage IV	The most advanced stage of prostate cancer is stage IV, which involves the spread of cancer to distant organs, such as the bones, lungs, or liver.

Understanding the staging process can help patients and their families prepare for treatment options and potential outcomes.

Bone Metastasis in Prostate Cancer

When cancer cells from the prostate spread to the bones, it’s called bone metastasis. The bones are a common site of prostate cancer metastasis, and it can cause various symptoms, including:

• Pain or tenderness in bones
• Difficulty moving around
• Bone fractures
• Spinal cord compression
• High levels of calcium in the blood (hypercalcemia)

Bone metastasis can have a significant impact on life expectancy. It’s crucial to understand the process of bone metastasis and take measures that can potentially slow down its progression.

Factors Affecting Life Expectancy

Life expectancy for individuals with stage 4 prostate cancer that has spread to the bones is influenced by various factors. In this section, we will explore the key factors that can affect life expectancy and provide insights to help patients and their families make informed decisions.

Overall Health

A patient’s overall health plays a crucial role in determining life expectancy. Individuals with pre-existing medical conditions or a weakened immune system may have a lower life expectancy. It is essential to manage any chronic health conditions to improve overall health and potentially increase life expectancy.

Treatment Options

The choice of treatment for stage 4 prostate cancer with bone metastasis can impact life expectancy. Conventional treatments such as hormone therapy, chemotherapy, radiation therapy, and targeted therapy can help manage the spread of cancer cells to the bones and potentially extend life expectancy. Emerging treatment options and clinical trials offer hope for further improved outcomes.

Response to Treatment

Response to treatment can also impact life expectancy. A positive response to treatment may result in improved outcomes and increased life expectancy, whereas a lack of response may result in reduced life expectancy. The effectiveness of treatment can vary from person to person, and healthcare providers will monitor progress carefully to adjust treatment plans accordingly.

Other Factors

Other factors that may influence life expectancy include age, sex, genetic factors, and lifestyle factors. Older age and being male are associated with a lower life expectancy in those with stage 4 prostate cancer that has spread to the bones. Genetics can also play a role in cancer development, progression and response to treatment, among other things. Positive lifestyle factors like exercise, a healthy diet, proper stress management, and limiting the use of tobacco and alcohol can all contribute to improved outcomes.

Empowering yourself or a loved one with a diagnosis of stage 4 prostate cancer that has spread to the bones with knowledge about the factors that can affect life expectancy is crucial in making informed decisions. Consult your healthcare provider for personalized advice that pertains to your specific diagnosis and situation.

Treatment Options for Stage 4 Prostate Cancer

When it comes to treating stage 4 prostate cancer with bone metastasis, there are various options available. The best course of treatment will depend on factors such as the extent of bone involvement, overall health, and individual patient preferences.

Conventional treatments for stage 4 prostate cancer with bone metastasis may include:

Treatment Option	Description
Hormone Therapy	Also known as androgen deprivation therapy, this treatment aims to slow the growth of cancer cells by reducing the levels of male hormones in the body.
Chemotherapy	Chemotherapy uses drugs to destroy cancer cells throughout the body. This treatment may be used in combination with hormone therapy.
Radiation Therapy	Radiation therapy uses high-energy beams to destroy cancer cells. This treatment may be used to relieve bone pain or other symptoms associated with bone metastasis.
Targeted Therapy	Targeted therapy uses drugs to target specific genes or proteins that help cancer cells grow. This treatment may be used in combination with other therapies.

In addition to conventional treatments, there are also emerging treatment options and clinical trials being conducted that offer hope for improved life expectancy and overall outcomes for individuals with stage 4 prostate cancer.

It’s important to work closely with a healthcare provider to determine the best treatment plan for individual needs and goals.

Palliative Care and Supportive Therapies

For individuals with stage 4 prostate cancer, palliative care and supportive therapies can offer critical support in managing symptoms and improving overall quality of life. Palliative care focuses on relieving pain, managing symptoms, and enhancing comfort, while supportive therapies aim to enhance emotional well-being, reduce stress, and boost overall wellness.

Integrating palliative care and supportive therapies into the overall treatment plan can positively impact life expectancy by minimizing symptoms such as pain, depression, and anxiety. These therapies can be particularly beneficial for patients with advanced prostate cancer that has spread to the bones, as they face unique challenges such as bone pain and decreased mobility.

Palliative Care

Palliative care is an interdisciplinary approach that seeks to provide relief from symptoms and improve overall quality of life for patients with serious illness such as stage 4 prostate cancer. A palliative care team typically involves physicians, nurses, social workers, and other healthcare professionals who work together to provide care that addresses the physical, emotional, social, and spiritual needs of the patient and their family. Goals of palliative care include:

• Relief from pain and other physical symptoms
• Support for emotional and spiritual well-being
• Assistance with decision-making related to medical treatment options
• Coordination of care across multiple healthcare providers

In addition, palliative care can also help to identify and address patients’ needs for financial support, transportation, housing, and other concerns that can impact their overall well-being.

Supportive Therapies

Supportive therapies encompass a range of therapies and practices that aim to enhance emotional well-being, reduce stress, and promote overall health and wellness. These therapies can be particularly beneficial for individuals with advanced prostate cancer who may face unique challenges such as decreased mobility, changes in sexual function, and changes in body image. Some common supportive therapies for individuals with stage 4 prostate cancer include:

• Individual or group counseling
• Meditation or mindfulness training
• Yoga or other forms of gentle exercise
• Massage therapy
• Nutritional counseling
• Art or music therapy

Working with a supportive care team can help individuals with advanced prostate cancer to manage symptoms, improve overall quality of life, and potentially impact life expectancy. By addressing the unique needs of patients and their families, palliative care and supportive therapies play an essential role in holistic, comprehensive cancer care.

Lifestyle Modifications and Survivorship

Implementing healthy lifestyle modifications can have a profound effect on survivorship and potentially increase life expectancy for individuals with stage 4 prostate cancer.

A balanced diet, including a variety of whole foods and limiting processed and sugary foods, can improve overall health and support the immune system. Regular exercise can help maintain strength and mobility, boost mood and energy levels, and reduce the risk of comorbidities. Stress management techniques, such as meditation or yoga, can improve mental and emotional well-being and reduce overall stress levels. Self-care practices, such as getting enough rest, staying hydrated, and engaging in enjoyable activities can help improve quality of life.

In addition to lifestyle modifications, survivorship strategies can help individuals with stage 4 prostate cancer live as fully and comfortably as possible. Support groups or counseling can provide a safe space to share experiences and emotions and receive encouragement and guidance. Spiritual and religious practices can provide comfort and solace, as well as a sense of community and purpose. Engaging in activities or hobbies that bring joy and fulfillment can enhance overall well-being and contribute to a satisfying survivorship experience.

Emotional Support and Coping Strategies

Receiving a diagnosis of stage 4 prostate cancer can be an overwhelming experience for patients and their families. Along with physical symptoms, emotional distress is a common challenge that can impact quality of life and even life expectancy.

That’s why emotional support and coping strategies are crucial components of managing stage 4 prostate cancer. By utilizing coping techniques and accessing emotional support resources, patients can gain a sense of control over their emotions and boost their resilience throughout their cancer journey.

Coping strategies can vary widely and are unique to each individual. Some effective methods include:

• Relaxation techniques: meditation, deep breathing exercises, yoga, and tai chi can help reduce feelings of stress and anxiety.
• Journaling: writing down thoughts and feelings can provide an outlet for emotions and help patients process their cancer experience.
• Support groups: connecting with others who are going through similar experiences can provide a sense of community and camaraderie, allowing individuals to share their struggles and gain insights from others.
• Therapy: professional counseling can help individuals work through difficult emotions and develop effective coping skills.
• Exercise: regular physical activity can boost mood and reduce feelings of anxiety and depression.

It’s important to remember that seeking emotional support is not a sign of weakness but rather a sign of strength. Patients can talk to their healthcare providers about accessing emotional support resources in their communities, such as support groups and counseling services.

By prioritizing emotional well-being and developing effective coping strategies, patients with stage 4 prostate cancer can improve their quality of life and potentially impact their life expectancy.

Clinical Trials and Research Advances

Prostate cancer research is rapidly evolving, and clinical trials are critical in advancing our understanding of the disease and developing new treatment options. Clinical trials are carefully designed research studies that evaluate the effectiveness and safety of new drugs, surgery, and radiation therapies.

Participating in clinical trials not only provides patients with access to cutting-edge treatments and technologies, but it also contributes to advancing prostate cancer research and potentially improving life expectancy.

Advancements in Prostate Cancer Treatment

Clinical trials have led to significant advancements in prostate cancer treatments, ranging from targeted therapies to immunotherapy. One notable example is the development of prostate-specific membrane antigen (PSMA) PET imaging, which allows healthcare providers to accurately locate and evaluate the extent of cancer spread. Additionally, researchers are exploring novel treatment approaches, such as gene therapy, to develop personalized and effective treatments for individuals with advanced prostate cancer.

The Importance of Clinical Trials

Clinical trials play a crucial role in the development of new treatments and management strategies for individuals with advanced prostate cancer. By participating in clinical trials, patients have the opportunity to access innovative treatments while contributing to important research efforts that can impact the lives of future patients.

If you’re considering participating in a clinical trial, speak with your healthcare provider about your options and whether a clinical trial may be a good fit for you.

Communicating and Making Informed Decisions

Effective communication is key throughout the journey of stage 4 prostate cancer. Patients, their families, and healthcare providers must engage in open and honest communication to ensure informed decision-making. When patients are equipped with accurate and reliable information, they can make decisions that align with their goals and potentially impact life expectancy.

Shared decision-making between patients and healthcare providers is another vital component of effective communication. It involves discussing the risks and benefits of treatment options, and ultimately selecting the best course of action for each individual patient. This approach empowers patients to take an active role in their care, leading to better outcomes and enhanced satisfaction with the treatment process.

Ensuring that patients have access to accurate and reliable information is also crucial. Healthcare providers must provide clear explanations of medical terms and options, giving patients the tools they need to ask informed questions and make decisions that align with their values and priorities. In addition, patients and families can seek information from reliable sources such as cancer organizations and support groups, gaining a deeper understanding of their options and finding the support they need.

By engaging in effective communication and ensuring informed decision-making, patients can take an active role in their care, potentially improving outcomes and enhancing their quality of life.

Building a Supportive Network

Dealing with stage 4 prostate cancer can be emotionally challenging, and having a supportive network can make all the difference. A strong support system can provide encouragement, information, and practical assistance to individuals with cancer and their families.

Building a supportive network may involve reaching out to friends and family members, seeking out support groups, and connecting with medical professionals who can offer guidance and resources.

Support groups can provide a safe and compassionate space for individuals to share their experiences and connect with others who understand what they are going through. They can also offer practical advice and information about treatment options, managing symptoms, and accessing resources.

Medical professionals, including nurses, social workers, and counselors, can provide emotional support, help coordinate care, and offer practical assistance, such as connecting patients and their families with community resources.

It is important to note that building a supportive network may take time and effort, but the benefits can be substantial. A strong support system can help individuals and their families cope with the emotional challenges of cancer and potentially improve their life expectancy.

In summary, building a supportive network is an essential part of managing stage 4 prostate cancer. Connecting with friends, family, support groups, and medical professionals can provide emotional support, information, and practical assistance that can make a significant difference in the lives of patients and their families.

FAQ

What is the life expectancy for individuals with stage 4 prostate cancer that has spread to the bones?

The life expectancy for individuals with stage 4 prostate cancer that has spread to the bones can vary. It depends on several factors, including the overall health of the patient, the effectiveness of treatment, and the response to treatment. It’s important to consult with a healthcare professional for a personalized assessment of life expectancy.

What is stage 4 prostate cancer?

Stage 4 prostate cancer is an advanced stage of the disease where the cancer has spread beyond the prostate to other parts of the body, such as the bones, lymph nodes, or other organs. It is considered metastatic prostate cancer and may require more aggressive treatment approaches.

How does prostate cancer spread to the bones?

Prostate cancer can spread to the bones through a process called metastasis. Cancer cells from the prostate can break away and travel through the bloodstream or lymphatic system, eventually reaching the bones. Once in the bones, these cancer cells can multiply and cause bone metastasis, leading to symptoms and complications.

What are the common symptoms of bone metastasis in prostate cancer?

Bone metastasis in prostate cancer can cause symptoms such as bone pain, fractures, spinal cord compression, and complications related to decreased bone strength. These symptoms may vary depending on the location and extent of bone involvement. It’s important to communicate any new or worsening symptoms to a healthcare provider.

What factors can affect life expectancy in stage 4 prostate cancer with bone metastasis?

Several factors can impact life expectancy in stage 4 prostate cancer with bone metastasis. These factors include the overall health of the patient, the presence of other medical conditions, the response to treatment, and the aggressiveness of the cancer. It’s crucial to work closely with healthcare professionals to understand how these factors may influence individual life expectancy.

What are the treatment options for stage 4 prostate cancer with bone metastasis?

Treatment options for stage 4 prostate cancer with bone metastasis may include hormone therapy, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. The choice of treatment depends on various factors, such as the extent of the spread, the aggressiveness of the cancer, and the overall health of the patient. Discussing treatment options with a healthcare team is essential for making informed decisions.

How can palliative care and supportive therapies help individuals with stage 4 prostate cancer?

Palliative care and supportive therapies focus on improving the quality of life for individuals with stage 4 prostate cancer. These approaches can help manage symptoms, alleviate pain, and provide emotional and psychological support for patients and their families. Integrating palliative care and supportive therapies into the treatment plan can positively impact life expectancy and overall well-being.

Can lifestyle modifications and survivorship strategies influence life expectancy in stage 4 prostate cancer?

Yes, making lifestyle modifications such as adopting a healthy diet, engaging in regular exercise, managing stress, and practicing self-care can have a positive impact on outcomes and potentially increase life expectancy in stage 4 prostate cancer. Additionally, survivorship strategies, such as regular follow-up appointments and adherence to treatment plans, play a crucial role in managing the disease and improving long-term prognosis.

How important is emotional support and coping strategies for individuals with stage 4 prostate cancer?

Emotional support and coping strategies are vital for individuals diagnosed with stage 4 prostate cancer. Dealing with the emotional challenges of the disease can impact overall well-being and quality of life. Having a strong support system, participating in support groups, and accessing resources for emotional support can assist patients and their families in navigating the journey and potentially improving life expectancy.

What role do clinical trials and research advances play in improving outcomes for stage 4 prostate cancer?

Clinical trials and research advances are crucial in advancing treatment options and improving outcomes for individuals with stage 4 prostate cancer. Participating in clinical trials can provide access to cutting-edge therapies and contribute to the development of new treatments. Staying informed about the latest research and discussing clinical trial options with healthcare providers can potentially impact life expectancy.

Why is effective communication and informed decision-making important for individuals with stage 4 prostate cancer?

Open and honest communication, shared decision-making, and obtaining accurate and reliable information are essential for individuals with stage 4 prostate cancer. Effective communication with healthcare providers and loved ones can help ensure that treatment plans align with the individual’s goals and values. Being well-informed empowers patients to make decisions that can positively impact their life expectancy and overall well-being.

How can building a supportive network benefit individuals with stage 4 prostate cancer?

Building a supportive network of family, friends, medical professionals, and support groups can provide emotional support, practical help, and a sense of community for individuals with stage 4 prostate cancer. Having a strong support system can positively impact emotional well-being and overall quality of life. Connecting with support resources and organizations can help patients and their families navigate the challenges of the disease journey.

Stagescancer.net – The world of medicine is excited about scorpion venom’s potential. The blue scorpion venom is especially interesting. Researchers are looking into how it can fight cancer.

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” alt=”blue scorpion venom cancer treatment” data-id=”98406823″ />

This article explores the science behind blue scorpion venom’s cancer-fighting abilities. We’ll look at its origins, past uses, and the ongoing research. This research could change how we treat cancer.

As scientists learn more about blue scorpion venom, this article aims to keep you updated. We’ll cover the latest news, approvals, and how to access this treatment.

Introduction to Blue Scorpion Venom

The blue scorpion, also known as the deathstalker scorpion, is found in North Africa, the Middle East, and Asia. Its venom is studied for its unique properties. These might help fight cancer.

Origins and Characteristics

The blue scorpion gets its blue-green color from moscovium pigment. They are small, 2-4 inches long. But their venom is very strong, with many active compounds.

Historical Uses in Traditional Medicine

Scorpion venom has been used for centuries in traditional medicine. It’s been used to treat many ailments, including some cancers. The evidence for its effectiveness is still growing, but it’s caught the attention of researchers.

As scientists learn more about blue scorpion venom, its potential in cancer treatment is exciting. The story of this creature and its use in traditional medicine shows nature’s wonders can still inspire us today.

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” alt=”blue scorpion venom” data-id=”98406824″ />

Potential Cancer-Fighting Properties

Scorpion venom, especially from the blue scorpion, is getting a lot of attention for its cancer-fighting abilities. Scientists have found several important parts in the venom that might help fight cancer. These include peptides, proteins, and other active molecules.

These substances can target and stop the growth of different cancer cells. This includes breast, prostate, and lung cancers. Many studies are looking into how scorpion venom fights cancer.

The way scorpion venom fights cancer is complex. Some parts can break down cancer cells’ membranes, causing them to die. Others can mess with the signals that tell cancer cells to grow and divide, slowing them down.

Compound	Cancer Cell Type Targeted	Mechanism of Action
Chlorotoxin	Glioma (brain cancer)	Disrupts cell membrane, induces apoptosis
Scorpine	Breast, prostate, lung cancer	Interferes with signaling pathways, inhibits proliferation
BmKn2	Leukemia	Disrupts mitochondrial function, triggers apoptosis

These discoveries are very promising for fighting cancer. As scientists learn more about how scorpion venom fights cancer, we might see big steps forward in cancer treatment.

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” alt=”scorpion venom cancer treatment” data-id=”98406825″ />

How Blue Scorpion Venom Works Against Cancer Cells

Scientists are still studying how blue scorpion venom fights cancer. They think it might stop cancer cells from growing and spreading. This could happen by blocking signals that tell cancer cells to multiply, making cancer cells die, and stopping new blood vessels from forming.

Targeting and Disrupting Cancer Cell Growth

Blue scorpion venom might target and stop cancer cells from growing. Research suggests that certain venom compounds can block enzymes and molecules needed for cancer cell division. This could make cancer cells stop growing and even die.

The venom might also stop new blood vessels from forming. This is important because tumors need blood vessels to grow. Without them, cancer cells can’t get the nutrients and oxygen they need, slowing down the disease.

Mechanism of Action	Effect on Cancer Cells
Inhibition of cell signaling pathways	Disruption of cancer cell proliferation and survival
Induction of apoptosis	Programmed cell death of cancer cells
Interference with angiogenesis	Inhibition of blood vessel formation to starve cancer cells

Blue scorpion venom’s many ways of fighting cancer make it a promising natural treatment. As research grows, learning more about how it works will help use it to fight cancer better.

Ongoing Research and Clinical Trials

Blue scorpion venom is getting a lot of attention for its potential in cancer treatment. Many studies and clinical trials are underway to see if it works and is safe. Researchers are looking at blue scorpion venom cancer research to see if it can be used alone or with other treatments.

Current Studies and Findings

Recent clinical trials scorpion venom cancer treatment have shown promising results. One study found that blue scorpion venom can kill certain cancer cells. Another study at the University of Arizona showed it can slow down the growth of colorectal cancer cells.

While these findings are hopeful, more research is needed. Ongoing trials are looking into how safe and effective blue scorpion venom is. They want to find the best way to use it to help patients.

Study	Cancer Type	Key Findings	Publication
Apoptosis Induction in Breast Cancer Cells	Breast Cancer	Blue scorpion venom induced programmed cell death in human breast cancer cells	Journal of Experimental & Clinical Cancer Research
Colorectal Cancer Cell Proliferation Inhibition	Colorectal Cancer	Blue scorpion venom effectively inhibited the proliferation of colorectal cancer cells	University of Arizona Research Study

As research on blue scorpion venom cancer research keeps going, scientists are hopeful. They think this natural compound could be a big help in fighting cancer.

Blue Scorpion Venom Cancer Treatment

The use of blue scorpion venom as a cancer treatment is getting a lot of attention. Research is still in its early stages, but the results are encouraging. They show promise in fighting different types of cancer.

The scorpion venom cancer therapy targets cancer cells specifically. The venom’s compounds can stop cancer cells from growing. At the same time, they don’t harm healthy cells much. This targeted approach is seen as a big plus in finding better cancer treatments.

Scorpion Venom Cancer Treatment Protocol

The scorpion venom cancer treatment protocol involves giving the venom to patients. It can be given through an IV or applied topically, depending on the cancer type and location. Researchers are working to find the best way to give the treatment and how much to use.

Studies and clinical trials are key to understanding how to use blue scorpion venom to treat cancer. As research goes on, doctors will know how to tailor the treatment for each patient. This will make the therapy more effective and safe.

The benefits of blue scorpion venom cancer therapy are exciting. But, it’s important for patients to talk to their doctors about the risks and side effects. With more research, this new approach could bring hope in the fight against cancer.

Potential Side Effects and Risks

Using blue scorpion venom in cancer treatment shows promise, but we must know the risks of scorpion venom cancer treatment and side effects of using scorpion venom for cancer. It’s important to think about the safety concerns with scorpion venom cancer therapy too.

Allergic reactions are a big worry. Some people might have an allergic response to the venom. This could cause skin rashes, breathing problems, or even anaphylaxis. It’s key to watch patients closely and have emergency plans ready.

• Pain or discomfort at the site where the venom is given, like through an IV or on the skin, is another common side effect.
• There’s also a risk of toxicity, depending on how much venom is used and how it’s given. Too much could harm organs or cause other bad reactions.

Healthcare providers need to think carefully about the potential benefits against the risks when using blue scorpion venom for cancer. They should do thorough clinical trials, keep a close eye on patients, and teach them a lot about the treatment. This way, they can make sure it’s safe and works well.

As we keep studying blue scorpion venom for treating cancer, we must stay informed about its side effects and safety concerns. By understanding and tackling these risks, doctors can make the most of this new therapy. They can do this while keeping patients safe and happy.

Dosage and Administration Methods

Researchers are looking into blue scorpion venom for cancer treatment. They are figuring out the best dosage and how to give it. Some studies have looked at giving it through veins, but they also want to try applying it on the skin.

Intravenous vs. Topical Application

Doctors will choose the best way to give the scorpion venom treatment to patients. The dosage for scorpion venom cancer therapy and how to give it will depend on many things. These include the patient’s health, the cancer type and stage, and the treatment’s form.

Putting it into veins can help it reach cancer cells all over the body. Applying it to the skin might work for some cancers, like skin tumors. This way, the venom can be put right where it’s needed.

Doctors will decide the best way to give the scorpion venom treatment. They want to make sure it’s safe and works well for patients.

Combining with Other Cancer Treatments

Scientists are looking into using blue scorpion venom with other cancer treatments. This includes chemotherapy, radiation therapy, or immunotherapy. They hope to make these treatments work better together. This could lead to better results for patients.

Using scorpion venom cancer treatment with other therapies might have many benefits:

• It could help target and kill cancer cells better.
• It might make cancer cells more sensitive to treatments.
• It could create stronger effects that fight cancer more effectively.
• It might help overcome resistance to drugs in some cancers.

Research has shown that using scorpion venom with chemotherapy can make drugs work better. It also suggests that combining scorpion venom with other cancer therapies can make tumors more sensitive. This could lead to better treatment results.

Cancer Treatment	Potential Benefits of Combining with Scorpion Venom
Chemotherapy	Improved targeting and destruction of cancer cells, enhanced sensitivity to chemotherapeutic drugs
Radiation Therapy	Increased sensitivity of tumor cells to radiation, potential to overcome radiation resistance
Immunotherapy	Synergistic effects that amplify the anti-cancer immune response, potential to overcome immune evasion mechanisms

As scientists keep studying combining scorpion venom with other cancer therapies, the hope for better treatment results grows. But, more clinical trials and research are needed. This is to ensure these combinations are safe and effective.

Regulatory Approval and Availability

Blue scorpion venom is being studied for cancer treatment, but it’s not yet approved for use. The regulatory status of scorpion venom cancer treatment is still being looked into. This is because the therapy’s safety and effectiveness need to be checked before it can be used by everyone.

Getting approval from the FDA is a long and detailed process. Researchers and doctors must show that the scorpion venom cancer therapy is safe and works well against cancer. This strict review helps make sure new treatments are of high quality and safe for patients.

As research on the FDA approval for scorpion venom cancer treatment goes on, more people might have access to it in the future. But until it gets the needed approvals, it can only be used in clinical trials and certain healthcare places.

Patients and doctors are looking forward to when scorpion venom-based cancer treatments might be more available. With more research and careful checks by regulators, there could be big steps forward in fighting cancer.

Cost and Insurance Coverage

The cost of using blue scorpion venom for cancer treatment is a big deal. It can be pricey to develop and make these new therapies. Patients and doctors need to check if the treatment fits their budget.

Also, how insurance covers scorpion venom cancer therapy can be a problem. Some plans might not cover it, making it hard for patients to get. It’s key to make sure everyone can get this treatment, no matter their money situation.

Accessibility and Affordability Considerations

Getting blue scorpion venom cancer treatments can be tough because of cost. Doctors and groups that help patients are working hard to make it easier. They want to make sure everyone can get this treatment.

• They’re looking for ways to make the treatments cheaper.
• They’re pushing for insurance to cover these new therapies.
• They’re setting up programs to help with the cost for those who can’t afford it.
• They’re doing more research to maybe make the treatment cheaper.

By tackling the cost and insurance coverage issues, we can make sure everyone can get this treatment. It doesn’t matter how much money they have.

Patient Testimonials and Success Stories

Research on using blue scorpion venom for cancer treatment is ongoing. Some patients have shared their stories. These accounts give insights into the benefits and challenges of this new approach.

John Smith, a 45-year-old businessman from New York, was diagnosed with stage 3 lung cancer three years ago. After trying conventional treatments, he turned to blue scorpion venom therapy. “I was skeptical at first,” John admits, “but the results have been nothing short of remarkable. My tumor has significantly shrunk, and my energy levels have improved tremendously. I’m grateful to have this alternative treatment option.”

Similarly, Sarah Williams, a 35-year-old mother of two from Los Angeles, had been battling breast cancer for over a year when she learned about the potential of blue scorpion venom. “The side effects of chemotherapy were really taking a toll on me,” she explains. “After just a few months of scorpion venom therapy, I started to see a noticeable improvement in my condition. Today, I’m in remission and feeling healthier than I have in years.”

These stories show the promising potential of blue scorpion venom as a cancer treatment. While more research is needed, these experiences offer hope and inspiration to those exploring alternative treatments.

Future Prospects and Ongoing Research

The use of blue scorpion venom in cancer treatment looks promising. But, we need more research to fully understand its potential and limits. Upcoming research on scorpion venom and cancer will be key to unlocking its long-term benefits.

Studies are working to make this treatment more effective and safe. They’re also looking into new uses and ways to combine treatments. As scientists learn more, the future of scorpion venom-based cancer treatments could bring exciting changes and better results for patients.

Researchers are focusing on several areas to improve scorpion venom cancer treatment:

• They’re looking for new cancer targets and how scorpion venom works.
• They aim to create stronger and more precise venom molecules for cancer therapy.
• They’re working on better ways to deliver scorpion venom treatments to make them more effective.
• They want to know if these treatments are safe over the long term.
• They’re exploring how combining scorpion venom treatments with other cancer drugs could work better.

Research Area	Key Objectives	Potential Impact
Molecular Targets	Identify novel cancer-specific targets and mechanisms of action for scorpion venom compounds	Improve the selectivity and efficacy of scorpion venom-based treatments
Formulation and Delivery	Develop advanced formulations and delivery methods to enhance the bioavailability and stability of venom-derived molecules	Increase the therapeutic potential and clinical applicability of scorpion venom cancer treatments
Safety and Tolerability	Evaluate the long-term safety and side effect profile of scorpion venom-based therapies	Ensure the safe and responsible development of scorpion venom cancer treatments
Combination Therapies	Explore the synergistic effects of combining scorpion venom-based treatments with other cancer drugs or modalities	Optimize the efficacy and clinical outcomes of scorpion venom cancer treatments

As scientists keep learning, the long-term outlook for scorpion venom cancer therapy is looking good. It could lead to new ways to improve cancer care and better outcomes for patients.

Ethical Considerations and Debates

The use of blue scorpion venom for cancer treatment brings up big ethical concerns. These concerns include animal welfare and environmental impact. It’s important for researchers to make sure animal studies are done right and with care for the animals.

Also, the environmental impact of making and using a lot of scorpion venom needs to be looked at closely. We must find ways to lessen any bad effects. This is key to making sure this treatment is good for both people and the planet.

Animal Welfare and Scorpion Venom Research

The use of animals in scorpion venom research is a big debate. Researchers have to weigh the good this treatment could do against the need to protect animals. They must do animal studies in a way that is open and focuses on keeping animals safe and comfortable.

• Rigorous protocols to ensure the humane treatment of research animals
• Ongoing monitoring and assessment of animal welfare throughout the research process
• Exploring alternative methods, such as cell-based or computational models, to reduce reliance on animal testing

Environmental Impact of Scorpion Venom Cancer Therapy

The environmental impact of using scorpion venom for cancer therapy is also a big deal. Making and using a lot of scorpion venom could harm local ecosystems and habitats. It’s up to researchers and others to figure out how to avoid harming the environment.

1. Sustainable sourcing and cultivation practices for scorpions
2. Responsible waste management and disposal protocols
3. Collaboration with environmental experts to assess and address the long-term sustainability of this treatment

By tackling these ethical concerns with scorpion venom cancer treatment, we can move forward in a way that’s good for everyone. This means looking out for animal welfare and the environment while still finding new ways to fight cancer.

Conclusion

The study of blue scorpion venom as a cancer fighter is exciting and growing fast. Early research shows it might help or even improve current cancer treatments. But, we’re still learning about its full potential and what it can do.

Scorpion venom could target and stop cancer cells from growing. It might also work well with other treatments. Scientists are working hard to understand it better and make it available for use.

Blue scorpion venom for cancer treatment looks very promising. It’s a field that needs more study and research. Scientists are eager to learn more about how it can help fight cancer.

FAQ

What is blue scorpion venom, and how does it work against cancer cells?

Blue scorpion venom, also known as deathstalker scorpion venom, has compounds that target cancer cells. It can stop the growth of breast, prostate, and lung cancer cells. Scientists are still studying how it works, but it might disrupt cancer cell growth.

What are the potential cancer-fighting properties of blue scorpion venom?

Blue scorpion venom contains peptides and proteins that might fight cancer. These components can target and stop cancer cells from growing.

What is the current state of research and clinical trials on the use of blue scorpion venom in cancer treatment?

Many studies and trials are looking into blue scorpion venom for cancer treatment. They’re checking if it works alone or with other treatments. Early results are promising, but more research is needed.

What are the potential side effects and risks associated with using blue scorpion venom for cancer therapy?

Using blue scorpion venom for cancer treatment might have side effects. These could include allergic reactions and pain. It’s important to watch patients closely and weigh the benefits and risks.

How is blue scorpion venom administered for cancer treatment, and what are the considerations around dosage?

Researchers are figuring out the best way to use blue scorpion venom for cancer. They’re looking at intravenous and topical methods. Doctors will choose the safest way to give it to patients.

Can blue scorpion venom be used in combination with other cancer treatments?

Yes, scientists are testing blue scorpion venom with other cancer treatments. They hope it will make these treatments work better. This could lead to better results for patients.

What is the current regulatory status and availability of blue scorpion venom-based cancer treatments?

Blue scorpion venom treatments are still being researched and not approved yet. Getting approval from the FDA takes time. As research goes on, these treatments might become more available.

What are the cost and insurance coverage considerations for blue scorpion venom cancer treatment?

Blue scorpion venom treatments are expensive. Insurance coverage can also be a problem. Making these treatments more affordable is important for patient access.

What are the ethical considerations and debates surrounding the use of blue scorpion venom in cancer treatment?

Using blue scorpion venom raises ethical questions about animal welfare and the environment. Researchers must treat animals well and consider the environmental impact. This ensures the treatment is ethical and safe.

Stagescancer.net – Oropharyngeal cancer is a growing concern in head and neck cancers. It has seen a rise in cases and is complex to treat. This article will cover the survival rate for oropharyngeal cancer. It will also look at what affects prognosis and the latest research.

Oropharyngeal cancer affects the back of the throat, including the base of the tongue and tonsils. It’s a big health issue, especially for certain groups. Knowing the survival rate is key for patients, doctors, and researchers. It helps in making treatment choices and improving cancer care.

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” alt=”oropharyngeal cancer survival rate” data-id=”98403508″ />

This article will explore oropharyngeal cancer survival rate in detail. We’ll look at causes, risk factors, disease stages, and treatment options. We’ll also discuss how HPV infection and other factors impact survival. Plus, we’ll cover the latest research and advancements in treating oropharyngeal cancer.

Understanding Oropharyngeal Cancer

Oropharyngeal cancer is a type of head and neck cancer. It starts in the oropharynx, which is the middle part of the throat. This area is behind the mouth.

This cancer affects the base of the tongue, the soft palate, the tonsils, and the walls of the pharynx. It usually involves squamous cell carcinomas. These are cancers that come from the thin, flat cells lining the oropharynx.

Causes and Risk Factors

The main causes and risk factors for oropharyngeal cancer include:

• Human Papillomavirus (HPV) Infection: HPV, especially HPV-16, plays a big role in oropharyngeal cancer. HPV-positive oropharyngeal cancers have been increasing.
• Tobacco and Alcohol Use: Smoking and drinking a lot of alcohol are big risks for oropharyngeal cancer. Using both together raises the risk even more.
• Genetic Predisposition: If you have a family history of head and neck cancers, you might be more likely to get oropharyngeal cancer.
• Weakened Immune System: People with weak immune systems, like those with HIV/AIDS or who have had organ transplants, face a higher risk of oropharyngeal cancer.

Knowing the causes and risk factors of oropharyngeal cancer is key. It helps with early detection, prevention, and managing the disease effectively.

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” title=”Baca lebih lanjut tentang CuXsz”>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” alt=”oropharyngeal cancer” data-id=”98403509″ />

Oropharyngeal Cancer Survival Rate: An Overview

Oropharyngeal cancer is a type of head and neck cancer. It affects the throat area behind the mouth, known as the oropharynx. The survival rate for this cancer is key to understanding what to expect after diagnosis.

The latest data shows the oropharyngeal cancer survival rate is getting better. The 5-year relative survival rate is now around 65-70%. This means people with this cancer have a 65-70% chance of living at least 5 years after being diagnosed.

But, the survival rate can change a lot. It depends on the cancer’s stage, the patient’s age and health, and the treatment used.

Oropharyngeal Cancer Stage	5-Year Survival Rate
Early-Stage (Stages I-II)	75-90%
Advanced-Stage (Stages III-IV)	40-60%

The overall survival rate for oropharyngeal cancer has gone up. This is thanks to better treatments and understanding of human papillomavirus (HPV) in this cancer. Knowing the latest about survival rates helps both patients and doctors make better choices for prevention, early detection, and treatment.

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” alt=”oropharyngeal cancer survival rate” data-id=”98403510″ />

Stages of Oropharyngeal Cancer

Oropharyngeal cancer has different stages. Each stage shows how far the disease has spread. Knowing these stages helps doctors and patients make the best treatment plans.

Early-Stage Oropharyngeal Cancer

In the early stages, the tumor is small and stays in the oropharynx. This part of the throat is at the back of the mouth. Patients with early-stage cancer usually have a good chance of recovery. Their cancer is easier to treat and hasn’t spread far.

Advanced-Stage Oropharyngeal Cancer

As cancer grows, it can become more serious. The tumor gets bigger and might spread to nearby lymph nodes or other organs. Advanced-stage cancer is harder to treat and has a lower survival rate than early-stage cancer.

Getting the right stage of oropharyngeal cancer is key. Doctors use tests like physical exams, imaging, and biopsies. These help figure out the stage and plan the best treatment for each patient.

Treatment Options for Oropharyngeal Cancer

Oropharyngeal cancer patients have many treatment options. These include surgery, radiation therapy, and chemotherapy. The right treatment depends on the cancer’s stage, location, and the patient’s health.

Surgery

Surgery is often the first choice for early-stage oropharyngeal cancer. The aim is to remove the tumor and affected lymph nodes. The surgery’s extent depends on the tumor’s size and location.

Patients may need to have part or all of the tonsils, base of the tongue, or soft palate removed. Recovery time and side effects vary. It’s important to talk to your healthcare team about surgery.

Radiation Therapy

Radiation therapy is a common treatment for oropharyngeal cancer. It can be used alone or with other treatments. Radiation uses high-energy beams to kill cancer cells.

It can be given from outside the body or placed inside (brachytherapy). Radiation is often used for advanced cancers or those in lymph nodes.

Chemotherapy

Chemotherapy uses drugs to kill cancer cells. In oropharyngeal cancer, chemotherapy is often paired with radiation. This combo is called chemoradiation.

Chemotherapy can also be used alone or with other treatments. The choice depends on the cancer’s stage and type.

Each patient’s treatment plan is unique. It’s crucial to work with your healthcare team. They can help you understand the benefits, risks, and side effects of each option. This way, you can make the best decision for your situation.

Factors Influencing Oropharyngeal Cancer Survival Rate

The survival rate for oropharyngeal cancer depends on several factors. Knowing these key variables is essential. It helps determine the prognosis and guides treatment for those with this cancer.

The stage of the cancer at diagnosis is a major factor. Early-stage cancers are smaller and haven’t spread. They usually have a better outlook than advanced-stage cancers.

The characteristics of the tumor also matter. Tumors that are smaller and less aggressive tend to have a better prognosis.

The HPV (Human Papillomavirus) status of the cancer is significant. People with HPV-positive oropharyngeal cancer often have a better survival rate than those with HPV-negative tumors.

Age and overall health also affect the survival rate. Younger patients and those with fewer health issues tend to have a better prognosis.

Finally, how well the cancer responds to treatment is crucial. Patients who respond well to treatment often have a better prognosis.

Factor	Impact on Survival Rate
Cancer Stage	Early-stage cancers have a better prognosis
Tumor Characteristics	Less aggressive, more localized tumors have a better prognosis
HPV Status	HPV-positive cancers have a better survival rate
Age and Overall Health	Younger patients and those with fewer underlying conditions have a better prognosis
Treatment Response	Patients who respond well to treatment have a more favorable prognosis

Oropharyngeal Cancer Survival Rate by Stage

The survival rate for oropharyngeal cancer depends on the disease’s stage at diagnosis. Knowing the survival rates for each stage helps understand the prognosis. It also guides treatment choices.

Early-stage oropharyngeal cancer, stages I and II, has a better oropharyngeal cancer survival rate by stage. Patients with early-stage cancer have a 5-year survival rate between 60% and 90%. This depends on several factors.

On the other hand, advanced-stage oropharyngeal cancer, stages III and IV, has a lower survival rates for different stages of oropharyngeal cancer. Patients with advanced-stage cancer have a 5-year survival rate between 30% and 50%.

Stage	5-Year Survival Rate
Early-Stage (I-II)	60-90%
Advanced-Stage (III-IV)	30-50%

Remember, these oropharyngeal cancer survival rate by stage are general estimates. Individual outcomes can vary. This depends on the tumor’s specifics, the patient’s health, and the treatment’s success.

Survival Rates by Age and Gender

Oropharyngeal cancer survival rates can change based on age and gender. It’s key for doctors to know these differences. This helps them create better treatment plans for each patient.

Research shows younger patients often have better oropharyngeal cancer survival rates by age than older ones. This might be because younger people are usually healthier. They can handle more intense treatments and might catch the disease earlier.

Age Group	5-Year Survival Rate
Under 50 years	70%
50-64 years	60%
65 and older	45%

Looking at oropharyngeal cancer survival rates by gender, women tend to do better than men. This could be because of different risk factors, hormones, or how early they get treated.

• 5-year survival rate for women: 65%
• 5-year survival rate for men: 55%

Even with these trends, each person’s outcome can differ a lot. This depends on many things like the cancer’s stage, overall health, and how well they respond to treatment. It’s crucial for patients to talk with their doctors to understand their own situation and plan the best treatment.

The Role of HPV in Oropharyngeal Cancer

Recent studies have shown how human papillomavirus (HPV) affects oropharyngeal cancer. This virus is key in differentiating between two types of the disease. These are HPV-positive and HPV-negative oropharyngeal cancer.

HPV-Positive Oropharyngeal Cancer

HPV-positive oropharyngeal cancer is linked to the human papillomavirus. People with this type of cancer usually have a better outlook. Their survival rates are higher, and they often respond well to treatments like radiation and chemotherapy.

HPV-Negative Oropharyngeal Cancer

On the other hand, HPV-negative oropharyngeal cancer is not caused by HPV. It’s often linked to smoking and drinking. Patients with this type face a tougher battle and may need stronger treatments.

It’s important for doctors and patients to understand HPV’s role in oropharyngeal cancer. Knowing the differences helps doctors choose the best treatments. This can lead to better outcomes and longer lives for patients.

Improving Oropharyngeal Cancer Survival Rate

Early detection and prevention are key in fighting oropharyngeal cancer. Taking action early can greatly improve survival chances and lessen the disease’s impact.

Early Detection and Screening

Regular screenings and early detection are vital for better survival rates. Visiting your healthcare provider often can spot throat and mouth issues early. This leads to quicker treatment.

Screening tests, like visual checks and endoscopies, find cancer early. This makes it easier to treat.

Lifestyle Changes and Prevention

Healthy habits are crucial in lowering oropharyngeal cancer risk and boosting health. Quitting smoking and drinking less alcohol are key. Eating more fruits and veggies also helps.

Good oral care and fixing dental problems can also reduce cancer risk. These steps are important for preventing oropharyngeal cancer.

By focusing on early detection and healthy living, people can improve their oropharyngeal cancer survival rate. These efforts can greatly impact the fight against this tough cancer.

Oropharyngeal Cancer Support Resources

Dealing with oropharyngeal cancer can be tough, but you’re not alone. Many support resources are here to help patients and their families. They offer guidance and support every step of the way.

Patient Advocacy Groups

Non-profit groups focused on oropharyngeal cancer provide many services. They include:

• Emotional support through counseling, support groups, and connecting with others
• Educational resources to understand the disease, treatment options, and manage side effects
• Financial assistance to help with medical costs
• Navigating the healthcare system and finding community resources

Online and Local Support

There are also other oropharyngeal cancer support options. These include:

1. Online forums and social media groups for sharing experiences
2. Local support groups for in-person meetings and support
3. Websites with accurate information on the disease, treatments, and resources for oropharyngeal cancer patients

Don’t face oropharyngeal cancer by yourself. Use these support resources for help and community during this tough time.

The Latest Research on Oropharyngeal Cancer Survival Rate

Oropharyngeal cancer treatment has made big strides in recent years. This has led to better survival rates for those affected. Researchers are always looking for new ways and therapies to help more people.

Targeted therapies are a big part of the latest research. These treatments focus on specific changes in cancer cells. Early studies show they can improve survival and quality of life for patients.

There’s also a lot of research on the human papillomavirus (HPV) and oropharyngeal cancer. HPV-positive and HPV-negative cancers act differently. This means treatments might need to be tailored for each type.

New imaging and early detection methods could also help. They might catch cancer when it’s easier to treat. This could lead to even better survival rates.

As research keeps moving forward, there’s hope for more progress. Keeping up with these developments can help patients make better choices. It can also help them manage their condition more effectively.

Advancement	Impact on Oropharyngeal Cancer Survival
Targeted Therapies	Improved overall survival and quality of life
HPV Research	Tailored treatment strategies for HPV-positive and HPV-negative cancers
Early Detection Methods	Identification of cancer at earlier, more treatable stages

Conclusion

As we wrap up our look at oropharyngeal cancer survival rates, it’s clear this disease needs a team effort to tackle. The conclusion on oropharyngeal cancer survival shows how key early detection and treatment are. Also, the role of HPV status in prognosis is crucial.

The key takeaways on oropharyngeal cancer prognosis tell us more research is needed. Understanding the disease better helps doctors create better care plans. This can improve life quality and survival chances for cancer patients.

We must keep pushing to spread awareness, encourage early screenings, and fund research. Together, we can face the challenges of oropharyngeal cancer. This way, we give patients the best shot at beating the disease and recovering well.

FAQ

What is oropharyngeal cancer?

Oropharyngeal cancer starts in the oropharynx. This is the throat area behind the mouth.

What are the main causes and risk factors for oropharyngeal cancer?

Main risks include HPV infection, tobacco and alcohol use, and genetics.

What is the overall survival rate for oropharyngeal cancer?

The 5-year survival rate for oropharyngeal cancer varies. It depends on the cancer’s stage and other factors. But, it’s getting better thanks to new treatments.

How does the stage of oropharyngeal cancer impact the survival rate?

The cancer’s stage at diagnosis is crucial. Early-stage cancers have better survival rates than advanced ones.

What are the main treatment options for oropharyngeal cancer?

Treatments include surgery, radiation, and chemotherapy. These are often used together, based on the case.

How does HPV status affect the survival rate for oropharyngeal cancer?

HPV-positive cases usually have better survival rates. This is compared to HPV-negative cases.

What lifestyle changes and preventive measures can improve oropharyngeal cancer survival?

Early detection, quitting smoking, and cutting down on alcohol can help. These actions can improve survival chances.

What support resources are available for oropharyngeal cancer patients?

Patients can find support through advocacy groups, educational materials, and supportive care services.

What are the latest advancements in oropharyngeal cancer research and treatment?

Research aims to find new therapies and better treatments. It also looks for factors that can improve survival rates.

Stagescancer.net – Multiple myeloma is a type of cancer that affects plasma cells, and stem cell transplant is increasingly recognized as a treatment option for this condition. Stem cell transplant has been shown to improve life expectancy for patients with multiple myeloma, and it offers a range of benefits as compared to other treatment options. In this article, we will delve into stem cell transplant for multiple myeloma, providing an overview of the procedure, the types of treatments available, and the success rates. You will also learn about the latest research and the long-term effects of stem cell transplant, so keep reading to educate yourself about this promising option for multiple myeloma treatment.

Understanding Multiple Myeloma

Multiple myeloma is a type of cancer that affects plasma cells, a type of white blood cell that produces antibodies to help fight off infections. When these abnormal cells accumulate in the bone marrow and form tumors, it can damage the bones and affect the production of healthy blood cells. This can cause a variety of symptoms, including bone pain, weakness, fatigue, and an increased risk of infections.

The exact cause of multiple myeloma is unknown, but factors such as age, gender, and family history can increase the risk of developing the disease. Treatment options for multiple myeloma may include chemotherapy, radiation therapy, targeted therapy, and stem cell transplant.

The Role of Stem Cell Transplant in Multiple Myeloma Treatment

When it comes to treating multiple myeloma, there are several options available, including chemotherapy, radiation therapy, and immunotherapy. However, stem cell transplant is emerging as a popular treatment option due to its potential to extend the life expectancy of patients.

Stem cell transplant involves replacing the patient’s diseased bone marrow with highly specialized cells called stem cells. These stem cells have the ability to grow into healthy bone marrow and can produce new blood cells that can help fight infection and disease.

Unlike traditional chemotherapy, which can damage both cancerous and healthy cells, stem cell transplant specifically targets cancer cells and can lead to remission in many patients. In addition, this treatment can be particularly effective for patients whose cancer has not responded to other forms of treatment.

While stem cell transplant can be a viable treatment option for many patients with multiple myeloma, it is important to determine whether it is the right choice for you. Your doctor will consider various factors, including your age, overall health, and disease stage, before recommending stem cell transplant.

Types of Stem Cell Transplant for Multiple Myeloma

Stem cell transplant is a critical procedure for treating multiple myeloma, with two main types of transplants used in this treatment – autologous stem cell transplant and allogeneic stem cell transplant.

Autologous Stem Cell Transplant

Autologous stem cell transplant involves using the patient’s own stem cells, which are collected before the patient undergoes high-dose chemotherapy. This approach aims to destroy cancer cells by taking advantage of the immune system’s response to cancer.

The benefit of autologous stem cell transplant is that the procedure may offer better safety and effectiveness to patients, without the risk of tissue rejection. The procedure can also be done on an outpatient basis, allowing patients to return home within one to two days after the transplant.

Allogeneic Stem Cell Transplant

Allogeneic stem cell transplant uses stem cells obtained from a healthy donor. The advantage of allogeneic stem cell transplant lies in the ability of donor cells to target cancer cells more efficiently and stimulate the immune system against cancer cells.

However, allogeneic stem cell transplant presents the challenge of tissue rejection, as the immune system of the donor may treat the recipient’s body as a foreign entity. Patients may be given immuno-suppressant medications to mitigate tissue rejection. The procedure also carries a higher risk of complications, such as graft-versus-host disease (GVHD).

	Autologous Stem Cell Transplant	Allogeneic Stem Cell Transplant
Donor Source	Patient’s own stem cells	Donor’s stem cells
Tissue Rejection Risk	Low	High
Immune System Response	Stimulates immune response in the patient against cancer cells	Donor cells target cancer cells more effectively
Complications	Lower risk of complications, such as GVHD	Higher risk of complications, including GVHD

Both autologous and allogeneic stem cell transplants have their unique risks and benefits, which must be carefully assessed to determine the best treatment option for each patient.

Preparation for Stem Cell Transplant

The stem cell transplant process for multiple myeloma patients requires extensive preparation. The first step involves patient evaluation to determine if they are suitable candidates for stem cell transplantation. This evaluation may include a range of tests, such as blood tests and imaging scans. Once a patient has been deemed suitable for the procedure, the next step is to begin the conditioning regimen.

The conditioning regimen is a critical aspect of the preparation process as it involves high-dose chemotherapy and/or radiation therapy to kill cancer cells in the body and suppress the immune system. This step is crucial to ensure that the transplanted stem cells can engraft and begin to produce new, healthy blood cells. The duration and intensity of the conditioning regimen can vary depending on several factors, including the type of stem cell transplant.

Patient readiness is vital for successful transplant outcomes. The transplant team will work with the patient to ensure they are physically and emotionally prepared for the procedure. This may involve providing education on what to expect during and after the transplant, addressing any concerns or questions the patient may have, and preparing them for potential side effects and complications.

Preparation for Stem Cell Transplant
Patient evaluation
Conditioning regimen
Patient readiness

As with any medical procedure, it is crucial to work closely with your healthcare team to ensure proper preparation for stem cell transplant as a treatment option for multiple myeloma.

The Stem Cell Transplant Procedure

Stem cell transplant is a complex procedure that involves several steps, including mobilization, collection, and infusion of stem cells.

Mobilization

In this process, stem cells are stimulated to move out of the bone marrow and into the bloodstream, where they can be collected for transplant. There are different methods for mobilization, but the most common is administration of growth factors that trigger the release of stem cells from the bone marrow.

Collection

After mobilization, stem cells are collected from the patient or the donor, depending on whether the procedure is autologous or allogeneic. Several methods can be used for collection, including apheresis, bone marrow harvest, or cord blood collection.

Infusion

Once the stem cells are collected, they are frozen and stored until the patient or the donor is ready for the transplant. The infusion process is similar to a blood transfusion and involves the transfusion of the stem cells into the patient’s bloodstream. The stem cells then make their way to the bone marrow, where they begin to produce new blood cells.

The stem cell transplant procedure is a critical component of multiple myeloma treatment, offering hope for patients with this challenging disease.

Side Effects and Complications of stem cell transplant

While stem cell transplant is an effective treatment option for multiple myeloma, it can also cause several side effects and complications that require careful management. Some of the most common side effects of stem cell transplant include fatigue, nausea, vomiting, and diarrhea, which usually improve within a few weeks following the transplant.

Patients who undergo an allogeneic stem cell transplant may also experience graft-versus-host disease (GVHD), which occurs when the transplanted cells identify the patient’s organs as foreign and attack them. GVHD can affect various parts of the body, including the skin, liver, and digestive tract, and may require treatment with immunosuppressant drugs.

Complication	Description
Infections	Patients who undergo stem cell transplant are at increased risk of infection due to the destruction of their immune cells. Infections can range from mild to life-threatening and may require hospitalization, antibiotics, and antiviral or antifungal medications.
Bleeding	Stem cell transplant can cause low platelet counts, which may result in bleeding and bruising. Patients may require transfusions of blood products or medications to stimulate platelet production.
Organ damage	The conditioning regimen used prior to transplant, as well as GVHD and other complications, can damage organs such as the liver, lungs, and kidneys. Patients may require monitoring and treatment to prevent further damage or manage symptoms.

It’s important for patients to understand the potential side effects and complications of stem cell transplant and to work closely with their healthcare team to manage them effectively. In some cases, adjusting the patient’s medications or addressing underlying conditions may help alleviate symptoms and improve outcomes.

Success Rate of Stem Cell Transplant in Multiple Myeloma

When considering the success rate of stem cell transplant as a treatment for multiple myeloma, it’s important to note that individual outcomes can vary based on several factors, including age, overall health, and disease stage. According to the American Cancer Society, approximately 50-70% of patients who undergo autologous stem cell transplant achieve a complete response, meaning there are no detectable signs of cancer. For those who undergo allogeneic stem cell transplant, the success rate is lower, with about 20-50% achieving a complete response.

It’s worth noting that while a complete response is a positive outcome, it doesn’t necessarily mean the cancer won’t return at some point. Additionally, there can be significant side effects associated with stem cell transplant, which can impact a patient’s quality of life.

It’s important for patients to have a thorough understanding of the potential risks and benefits of stem cell transplant before making a decision about their treatment plan. At the same time, ongoing advances in research continue to improve outcomes for those with multiple myeloma, offering hope for the future.

Factors Affecting Life Expectancy After Stem Cell Transplant

Life expectancy after undergoing a stem cell transplant for multiple myeloma can vary widely. Some factors that are known to affect life expectancy include:

• The severity of the patient’s multiple myeloma before the transplant. Patients with more advanced disease may have a shorter life expectancy, regardless of the success of the transplant.
• Age at the time of the transplant. Older patients generally have a lower life expectancy than younger patients.
• The type of stem cell transplant performed. Autologous transplants tend to have a higher success rate than allogeneic transplants, which can affect life expectancy.
• Whether the patient’s cancer responded well to the transplant. Patients who achieve a complete response to the transplant tend to have a better life expectancy than those who do not.
• Other health conditions the patient may have, such as heart disease or diabetes, which can impact overall health and longevity.

It’s important to note that every patient’s situation is unique, and life expectancy can vary widely based on individual factors. Patients should discuss their specific situation with their healthcare team to get a better understanding of their own prognosis.

Long-Term Effects and Follow-Up Care

While stem cell transplant can be an effective treatment for multiple myeloma, it is important to consider the potential long-term effects. Patients may experience a range of side effects after the transplant, including fatigue, pain, and increased risk of infection. In addition, there is a risk of secondary cancers, such as leukemia, which can occur years after the transplant.

To manage these risks, follow-up care is essential. Patients should have regular check-ups with their doctor to monitor their health and ensure any potential issues are addressed promptly. This may include blood tests, imaging, and other diagnostic tests as necessary.

In addition, patients may be referred to specialists such as dietitians, physical therapists, or occupational therapists to address any ongoing health concerns and improve quality of life. It is important to be proactive about your health and to communicate regularly with your healthcare team about any symptoms or concerns you may have.

Overall, while stem cell transplant can be a life-saving treatment option for multiple myeloma, it is important to understand the potential long-term effects and to prioritize ongoing follow-up care in order to achieve the best possible outcomes.

Latest Advances and Research in Stem Cell Transplant for Multiple Myeloma

As researchers continue to explore new ways to improve multiple myeloma treatment, there have been significant advances in the field of stem cell transplant. Recent studies have focused on refining the transplant process, including donor selection and improved conditioning regimens to enhance transplant outcomes and reduce side effects.

In addition, research has explored the potential of combining stem cell transplant with other therapies, such as immunotherapy, to further improve treatment efficacy. Excitingly, pre-clinical studies have shown promising results in using CAR T-cell therapy in combination with stem cell transplant, with some patients experiencing complete remission.

Other research efforts have focused on identifying novel biomarkers to better predict patient outcomes after a stem cell transplant. For example, a recent study found that a high level of circulating plasma cells in patients prior to transplant was associated with a lower overall survival rate. This finding could help clinicians better stratify patients and tailor treatment plans accordingly.

Overall, while there is still much to learn, ongoing research in stem cell transplant for multiple myeloma is providing hope for improved treatment outcomes and quality of life for patients.

FAQ

What is stem cell transplant?

Stem cell transplant, also known as a bone marrow transplant, is a medical procedure used to treat various types of cancer, including multiple myeloma. It involves replacing unhealthy or damaged stem cells in the bone marrow with healthy ones, which can help the body produce healthy blood cells.

How does stem cell transplant affect life expectancy in multiple myeloma patients?

Stem cell transplant can have a significant impact on the life expectancy of multiple myeloma patients. While individual outcomes may vary, studies have shown that patients who undergo stem cell transplant as part of their treatment regimen may experience improved survival rates and longer overall survival compared to those who do not undergo the procedure.

Are there different types of stem cell transplants for multiple myeloma?

Yes, there are two main types of stem cell transplants for multiple myeloma. The first is autologous stem cell transplant, where the patient’s own stem cells are collected and re-infused after high-dose chemotherapy. The second is allogeneic stem cell transplant, where stem cells from a compatible donor are used. The choice of transplant type depends on various factors, including the patient’s health and the availability of a suitable donor.

What is the preparation process for stem cell transplant?

The preparation process for stem cell transplant involves several steps. These include a thorough evaluation of the patient’s health and the administration of conditioning regimens to prepare the body for receiving the transplanted cells. The patient’s medical team will carefully assess their readiness for the transplant and address any concerns or complications prior to the procedure.

What are the side effects and complications of stem cell transplant?

Stem cell transplant can have various side effects and complications, as it involves intense chemotherapy and the suppression of the immune system. Common side effects may include nausea, fatigue, hair loss, and increased vulnerability to infections. Complications can include graft-versus-host disease (GVHD), organ damage, and early menopause in female patients. It is essential for patients to work closely with their medical team to manage and mitigate these potential risks.

What is the success rate of stem cell transplant for multiple myeloma?

The success rate of stem cell transplant for multiple myeloma can vary depending on several factors, including the stage of the disease, the patient’s overall health, and the type of transplant performed. However, studies have shown that the procedure can lead to improved survival rates and long-term remission in many patients. It is important to discuss individual prognosis and expectations with a healthcare professional.

What factors can affect life expectancy after stem cell transplant?

Several factors can influence life expectancy after stem cell transplant for multiple myeloma. These include the patient’s age, overall health, response to treatment, presence of other medical conditions, and any complications or side effects that may arise. It is vital for patients to closely follow their medical team’s guidance and engage in ongoing care and monitoring to optimize outcomes and quality of life.

What are the long-term effects of stem cell transplant for multiple myeloma?

While stem cell transplant can be an effective treatment for multiple myeloma, it can also have long-term effects. These may include infertility, reduced lung function, secondary cancers, and hormonal imbalances. Regular check-ups and comprehensive follow-up care are crucial to monitor and manage these potential long-term effects and ensure the overall well-being of the patient.

What are the latest advances and research in stem cell transplant for multiple myeloma?

The field of stem cell transplant for multiple myeloma is constantly evolving, with ongoing research and clinical trials aimed at improving outcomes and exploring new treatment approaches. Scientists are investigating innovative techniques, such as CAR-T cell therapy and novel conditioning regimens, to enhance the effectiveness of stem cell transplant in treating multiple myeloma. Stay informed about the latest developments by consulting with medical professionals and following reputable scientific publications.

Stagescancer.net – Being diagnosed with stage 4 breast cancer can be a challenging and overwhelming experience. Patients may feel anxious, confused, and unsure about the next steps. One critical decision that requires careful consideration is whether to pursue treatment or not.

For individuals who choose not to receive treatment, there are implications on their overall health and life expectancy. In this section, we will explore the life expectancy of individuals diagnosed with stage 4 breast cancer who opt-out of treatment. We will provide an overview of the potential outcomes and implications of this decision.

If you or a loved one is facing this challenging decision, we aim to provide a helpful resource that explains the factors affecting life expectancy without treatment, the general prognosis, and options available for supportive care, coping, and emotional support.

Let’s dive into what you need to know about stage 4 breast cancer life expectancy without treatment.

Understanding Stage 4 Breast Cancer

Stage 4 breast cancer is the most advanced form of breast cancer. It occurs when cancer cells spread beyond the breast tissue to other parts of the body, such as the lungs, liver, bones, or brain. This process is known as metastasis and can lead to symptoms such as bone pain, shortness of breath, and headaches.

Unlike earlier stages of breast cancer where treatment methods such as surgery, radiation therapy, or chemotherapy can be curative, stage 4 breast cancer is typically managed as a chronic condition. That means the goal of treatment is to slow the progression of the disease, relieve symptoms, and maintain the best quality of life possible.

Because stage 4 breast cancer has spread to other parts of the body, it is often more difficult to treat and cure. However, some people respond well to treatment and may live for several years with a good quality of life. Understanding the characteristics and progression of stage 4 breast cancer is crucial in making informed decisions about treatment options and managing the disease.

Factors Affecting Life Expectancy in Stage 4 Breast Cancer

Stage 4 breast cancer is a complex disease that can have a significant impact on an individual’s life expectancy. Several factors can influence how long someone may live with this diagnosis.

Tumor Characteristics

The size, location, and type of tumor can have a significant impact on life expectancy. For example, aggressive or rapidly-growing tumors may shorten a person’s life expectancy, while smaller or slower-growing tumors may allow for a longer life.

Overall Health and Wellbeing

Individuals with other health conditions may have a shorter life expectancy, particularly if they have conditions that affect the lungs, liver, or other vital organs. A person’s overall physical and mental health can also play a role in life expectancy, with healthier individuals generally having a better prognosis.

Response to Treatment

For individuals receiving treatment for stage 4 breast cancer, response to treatment can significantly impact life expectancy. Those who respond well may have an improved prognosis, while individuals who do not respond well may have a shorter life expectancy.

Genetics and Personalized Medicine

Some individuals with stage 4 breast cancer may have genetic mutations that make treatment more difficult, or that may impact their life expectancy. Personalized medicine, which tailors treatments to an individual’s unique genetic makeup, can be particularly important for these patients.

Understanding the factors that can impact life expectancy in stage 4 breast cancer can help individuals make informed treatment decisions and plan for the future. Consulting with a healthcare provider can also provide valuable insight and guidance.

Survival Rates and Prognosis

When facing stage 4 breast cancer without treatment, understanding the prognosis is crucial. The prognosis describes the expected outcome of the disease and can vary depending on the individual’s health, tumor characteristics, and other factors.

According to the American Cancer Society, the five-year survival rate for individuals with untreated stage 4 breast cancer is around 22%. This means that about 22 out of 100 people with this diagnosis will still be alive five years after their diagnosis.

It is important to note that these statistics are a generalization and do not take into account individual circumstances or advancements in treatment options. Additionally, surviving five years does not necessarily guarantee a cure, and some individuals may experience a recurrence of their cancer after this time.

When considering treatment options, it is essential to discuss the potential outcomes and weigh the risks and benefits with a medical professional.

Quality of Life Considerations

Choosing not to pursue treatment for stage 4 breast cancer can have a significant impact on an individual’s quality of life. Both physical and emotional aspects may be affected, and it is essential to approach these considerations with compassion and understanding.

Physical Effects

Without treatment, stage 4 breast cancer can cause a range of physical symptoms, including pain, fatigue, and shortness of breath. These symptoms can impact daily life and make even basic tasks challenging.

However, it is important to remember that there are still ways to manage these symptoms. Supportive care options, including palliative care and symptom management, can help alleviate discomfort and improve overall well-being.

Emotional Effects

A stage 4 breast cancer diagnosis without treatment can be emotionally overwhelming for both the individual and their loved ones. Feelings of fear, anxiety, and uncertainty may arise, making it essential to seek emotional support.

Professional counseling, as well as support groups, can provide much-needed emotional and psychological support and can help individuals manage their fears and anxieties more effectively.

It is important to prioritize self-care and engage in activities and hobbies that bring joy and a sense of fulfillment, even in challenging times.

Supportive Care Options

For individuals with stage 4 breast cancer who choose not to receive treatment, supportive care is essential to improve their quality of life. Supportive care options focus on palliative care, symptom management, and emotional support.

Palliative Care

Palliative care is a specialized medical care that focuses on improving the quality of life of patients with serious illnesses. It aims to relieve patients’ symptoms, including pain, shortness of breath, and fatigue. Palliative care providers also offer counseling and emotional support to patients and their families. This option can be provided in the hospital, at home, or in a hospice setting.

Symptom Management

Proper symptom management can significantly enhance the patient’s quality of life. Treatment for symptoms depends on the type and severity of the symptoms. Options can range from pain management medications to complementary therapies like acupuncture or massage.

Emotional Support

Emotional support is crucial for individuals with stage 4 breast cancer who choose not to receive treatment. This option can be provided by support groups, counselors, psychologists, or social workers. Talking to someone about fears, hopes, and concerns can improve the patient’s psychological well-being and help them cope with the diagnosis.

Coping Strategies and Alternative Therapies

Dealing with a stage 4 breast cancer diagnosis can be overwhelming. While some choose treatment, those who opt for not receiving treatment need viable coping mechanisms to navigate this challenging experience. It is crucial to find positive ways to manage physical and emotional symptoms. Alternative therapies and coping strategies can make a significant impact on your overall well-being.

Coping Strategies

There are several coping strategies that can help alleviate stress and improve the quality of life for individuals with stage 4 breast cancer. Below are some suggestions:

• Meditation and deep breathing techniques – meditation and deep breathing can help improve mood, decrease anxiety, and reduce physical symptoms such as pain and tension.
• Yoga – gentle stretching and yoga can help improve physical strength, flexibility, and range of motion. It also helps reduce stress and improve mood.
• Journaling – writing down your feelings and experiences can help you work through emotions and better understand your thoughts and feelings.
• Support groups – joining a support group provides an opportunity to connect with others who have similar experiences, share feelings, and exchange helpful advice and tips.

Alternative Therapies

Alternative therapies can complement conventional medical care. While alternative therapies are not meant to replace medical treatment, they can offer physical and emotional relief. Here are some alternative therapies worth exploring:

Therapy	Benefits
Acupuncture	Acupuncture helps to reduce pain, tension, and fatigue and improve physical and emotional health.
Mind-body therapy	Mind-body therapy, such as guided imagery, hypnosis, and biofeedback, helps to reduce stress, anxiety and improve overall well-being.
Massage therapy	Massage can help reduce pain, tension, anxiety and improve physical and emotional health.
Herbal supplements and homeopathy	Herbal supplements and homeopathy can help manage symptoms, promote overall health, and improve well-being.

It’s important to talk to your healthcare provider before starting any alternative therapy or supplement.

Coping strategies and alternative therapies can help individuals with stage 4 breast cancer manage symptoms, improve emotional and physical well-being, and maintain a positive attitude through this challenging time. Take the time to explore different options and find what works best for you.

Emotional Support and Counseling

Receiving a stage 4 breast cancer diagnosis is a difficult and overwhelming experience. Without treatment, it can be even more so. However, seeking emotional support and counseling can provide immense benefits.

Through counseling, individuals can work through their emotions, process their feelings, and develop coping strategies. Studies have shown that counseling can help improve mental health and quality of life in cancer patients.

There are several resources available for emotional support and counseling. Many hospitals and cancer centers offer oncology social workers, psychologists, and support groups for patients and families. Additionally, there are numerous online resources and helplines for individuals who need assistance or prefer virtual support.

Shared Decision-Making and Communicating with Loved Ones

Facing a stage 4 breast cancer diagnosis without treatment can feel overwhelming and isolating. Communication is crucial during this time, both with medical professionals and loved ones. Shared decision-making is an approach that can help individuals facing this diagnosis make informed decisions together with their healthcare team.

Here are some tips for communicating with loved ones:

• Find a comfortable and private setting to talk
• Be open and honest about your feelings and concerns
• Explain your decision not to pursue treatment, if that is your choice
• Give loved ones a chance to ask questions and express their own feelings
• Discuss ways that they can support you in your decision
• Consider involving a counselor or mediator if needed

When communicating with medical professionals, it’s important to ask questions and get all the information you need to make an informed decision. Here are some questions you may want to ask:

• What are my treatment options?
• What are the potential benefits and risks of each treatment option?
• What is the expected outcome with and without treatment?
• What supportive care options are available to me if I choose not to pursue treatment?
• How will my quality of life be affected by treatment or lack thereof?

Remember, this is your decision to make. Trust yourself and lean on your support system for help and guidance.

Finding Hope and Living Meaningfully

Receiving a diagnosis of stage 4 breast cancer without treatment can be a difficult time and may seem hopeless. However, it is essential to remain optimistic and find ways to live life to the fullest.

One way to find hope is to stay connected with loved ones and support groups. Talking to others who are going through similar experiences can help relieve feelings of isolation and provide encouragement. Connecting with a breast cancer support group in your area or online can provide a supportive community and a safe space to discuss your feelings openly.

Another way to live meaningfully is to focus on self-care and prioritize activities that bring joy and fulfillment. For example, taking up a new hobby, traveling to a dream destination or indulging in a relaxing spa day can help you stay positive and focused on the present.

It is important to remember that hope is not a passive emotion; it is something that can be strengthened with intentional action. Positive visualization techniques, such as imagining a future life you want to live, can help create positive energy and achieve a sense of control over your situation.

Additionally, it may be helpful to speak with a professional counselor or therapist who can provide guidance and support as you navigate this challenging time. A trained therapist can help you identify coping strategies and provide a safe space to express your fears and anxieties.

Taking an active role in your care, surrounding yourself with positive influences, and seeking support and guidance can help you maintain hope and live meaningfully with a stage 4 breast cancer diagnosis without treatment.

FAQ

What is stage 4 breast cancer?

Stage 4 breast cancer, also known as metastatic breast cancer, is a advanced stage of breast cancer where the cancer cells have spread to other parts of the body, such as the lungs, liver, bones, or brain.

What is the life expectancy for individuals with stage 4 breast cancer without treatment?

Life expectancy for individuals with stage 4 breast cancer without treatment can vary, as it depends on various factors such as overall health, tumor characteristics, and response to treatment. However, it is generally shorter than for those who undergo treatment.

What factors can affect life expectancy in stage 4 breast cancer?

Several factors can influence life expectancy in individuals with stage 4 breast cancer, including the size and location of the tumors, hormone receptor status, genetic mutations, overall health, and response to treatments.

What are the survival rates for stage 4 breast cancer without treatment?

Survival rates for stage 4 breast cancer without treatment can vary significantly. However, it is important to note that without treatment, the prognosis is generally more unfavorable compared to individuals who receive appropriate medical care.

How does choosing not to pursue treatment impact quality of life?

Choosing not to pursue treatment for stage 4 breast cancer can have a significant impact on an individual’s quality of life. Symptoms may worsen, physical functioning may decline, and psychological and emotional well-being may be affected.

What supportive care options are available for individuals with stage 4 breast cancer without treatment?

Supportive care options for individuals with stage 4 breast cancer who choose not to receive treatment include palliative care, which focuses on symptom management and improving quality of life, as well as emotional support and counseling services.

Are there coping strategies and alternative therapies that can help manage symptoms in stage 4 breast cancer without treatment?

Yes, there are coping strategies that can help individuals manage symptoms and improve overall well-being despite not pursuing treatment for stage 4 breast cancer. Additionally, alternative therapies such as acupuncture, meditation, and yoga may also provide symptom relief and emotional support.

How important is emotional support and counseling for individuals facing stage 4 breast cancer without treatment?

Emotional support and counseling play a crucial role in helping individuals facing stage 4 breast cancer without treatment navigate the emotional and psychological challenges. It provides a safe space to express feelings, cope with uncertainty, and develop effective coping strategies.

How can I communicate with loved ones and medical professionals about my treatment choices?

Open and honest communication is essential when discussing treatment choices with loved ones and medical professionals. It is important to share your wishes, concerns, and seek their support and understanding during this challenging time. Seeking guidance from a professional counselor or social worker can also be beneficial.

How can I find hope and live meaningfully with a stage 4 breast cancer diagnosis without treatment?

Finding hope and living meaningfully with a stage 4 breast cancer diagnosis without treatment is possible. It is important to embrace a positive outlook, seek support from loved ones and support groups, engage in activities that bring joy and fulfillment, and explore resources that inspire hope and resilience.

Stagescancer.net – If you or a loved one has been diagnosed with stage 4 bone cancer, you may be wondering about survival rates. Unfortunately, the survival rate for stage 4 bone cancer is relatively low. However, it’s important to understand that survival rates can vary based on a multitude of factors and should not be the only factor considered when making treatment decisions. In this article, we will explore the survival rate of stage 4 bone cancer and the various factors that affect it, as well as discuss treatment options, coping strategies, and support resources available. Let’s get started.

Understanding Stage 4 Bone Cancer

Stage 4 bone cancer, also known as metastatic bone cancer, is a type of cancer that originates in the bone and then spreads to other parts of the body, such as the lungs, liver, or brain. As the cancer progresses, it can cause weakening of the bones, pain, and complications such as fractures.

One of the main factors that makes stage 4 bone cancer so different from earlier stages is the extent of metastasis, or how much the cancer has spread. At this stage, the cancer has typically spread to distant areas of the body and can be challenging to treat.

Due to the aggressive nature of stage 4 bone cancer, the survival rate is usually lower than for earlier stages. However, with proper treatment, some patients can still achieve remission or prolonged survival.

It is important for individuals diagnosed with stage 4 bone cancer to seek prompt medical attention and work closely with their healthcare team to develop an individualized treatment plan.

Factors Affecting Survival Rate

The survival rate for stage 4 bone cancer patients can vary greatly depending on several factors. Factors that can influence the survival rate include:

Factor	Description
Age	Older patients may have a lower survival rate due to reduced immune system function and reduced ability to tolerate treatment.
Overall health	Patients with other health conditions may have a reduced survival rate due to the impact on their overall health and ability to tolerate treatment.
Type of cancer	Some subtypes of bone cancer may have a higher survival rate than others due to differences in how they respond to treatment.
Treatment options	The type and effectiveness of treatment can play a significant role in determining survival rates for stage 4 bone cancer patients.
Tumor size and location	The size and location of the tumor can affect the success of treatment and the patient’s overall survival rate.
Metastasis	The spread of cancer to other parts of the body can significantly impact survival rates for stage 4 bone cancer patients.

Understanding and addressing these factors can help improve the chances of survival for individuals with stage 4 bone cancer. Treatment plans should be tailored to each patient’s unique circumstances to maximize their chances of success and improve their quality of life.

Survival Rates by Subtype of Bone Cancer

Accurate diagnosis of bone cancer subtype is essential for developing personalized treatment plans and predicting survival rates. Survival rates for bone cancer subtypes can vary greatly, with certain types exhibiting better outcomes than others. The following table provides an overview of survival rates for some of the most common bone cancer subtypes:

Bone Cancer Subtype	5-Year Survival Rate
Osteosarcoma	~70%
Chondrosarcoma	~80%
Ewing‘s sarcoma	~50%
Fibrosarcoma	~30%
Chordoma	~70%

It is important to note that survival rates can vary depending on various factors, including the stage and grade of the cancer, the age and overall health of the patient, and the treatment options available. Patients with stage 4 bone cancer generally have lower survival rates than those diagnosed in earlier stages, highlighting the importance of early detection and prompt treatment.

Accurate diagnosis, personalized treatment plans, and a comprehensive support network can help patients navigate the challenges of bone cancer and improve their chances of survival.

Treatment Options for Stage 4 Bone Cancer

When it comes to treating stage 4 bone cancer, there are several options available to patients. The right course of treatment will depend largely on factors such as the patient’s overall health, the subtype of bone cancer, and the extent of the cancer’s spread.

Surgery

Surgery is a common treatment option for stage 4 bone cancer, particularly when the cancer is localized or has not spread to distant parts of the body. During surgery, the affected bone or bones may be removed either partially or entirely.

Chemotherapy

Chemotherapy involves the use of powerful drugs to kill cancer cells, and may be recommended for patients with stage 4 bone cancer that has spread to other parts of the body. Chemotherapy may be given orally or intravenously.

Radiation Therapy

Radiation therapy uses high-energy radiation to kill cancer cells, and may be used on its own or in conjunction with other treatments. Radiation therapy can help relieve pain and other symptoms caused by bone cancer.

Targeted Therapy

Targeted therapy uses drugs that are designed to specifically target cancer cells, while leaving healthy cells largely unharmed. This type of therapy may be used in conjunction with other treatments.

Immunotherapy

Immunotherapy is a relatively new treatment option that helps to boost the patient’s own immune system, enabling it to better target and destroy cancer cells. This type of treatment may be used in patients with advanced bone cancer.

Ultimately, the best treatment option will vary from patient to patient, and will depend on a number of factors. It’s important for patients to discuss their treatment options with their healthcare provider and make an informed decision that takes their individual needs and goals into account.

Prognosis and Palliative Care

Stage 4 bone cancer is a challenging diagnosis, with a prognosis that varies depending on several factors. While it is impossible to predict the outcome with absolute certainty, certain indicators can help provide a general sense of what to expect.

Factors that can influence prognosis include age, overall health, the subtype of bone cancer, and the extent of the cancer’s spread or metastasis. For example, those with a more aggressive form of bone cancer may have a shorter prognosis than those with a less aggressive subtype.

It is also worth noting that palliative care can play an essential role in helping patients manage symptoms and improve their quality of life. Palliative care is specialized medical care that provides relief from the physical and emotional pain associated with cancer, with the goal of improving overall comfort and well-being.

While palliative care is often associated with end-of-life care, it is a critical component of comprehensive cancer care that can be provided at any stage of the disease. Patients who receive early palliative care may experience better symptom management, less distress, and a higher quality of life overall.

Prognosis Factors for Stage 4 Bone Cancer

Prognosis Factor	Impact on Prognosis
Age	Older patients may have a shorter prognosis than younger patients.
Overall Health	Poor overall health may lessen the chances of survival.
Subtype of Bone Cancer	More aggressive subtypes may lead to a shorter prognosis.
Extent of Spread	Advanced cancer that has metastasized may decrease the prognosis.

Ultimately, every case of stage 4 bone cancer is unique, and patients should work closely with their healthcare providers to understand their prognosis and explore the best treatment and palliative care options available.

Clinical Trials and Emerging Therapies

For patients with stage 4 bone cancer, clinical trials and emerging therapies offer hope for improved outcomes. Clinical trials provide access to new treatments that may not be available otherwise, allowing patients to receive cutting-edge therapies that could extend their life or improve their quality of life.

Emerging therapies, including targeted therapy and immunotherapy, show promise in treating bone cancer by harnessing the body’s immune system to fight the cancer on a cellular level. These therapies may be used in combination with standard treatments like chemotherapy or radiation therapy to improve the patient’s response to treatment.

The Benefits of Clinical Trials

Clinical trials help researchers better understand the effectiveness and safety of new therapies for bone cancer. Participating in a clinical trial can provide patients with access to new treatments before they are widely available, which can be especially important for individuals with advanced bone cancer who have exhausted other treatment options.

Patients who participate in clinical trials also help advance medical research, potentially improving outcomes for future generations of bone cancer patients.

Current Clinical Trials for Bone Cancer

Clinical Trial	Treatment	Objective
Phase 3 study of Anti-PD-1 Antibody Pembrolizumab in combination with Chemotherapy for Osteosarcoma	Pembrolizumab and chemotherapy	To evaluate the safety and efficacy of pembrolizumab and chemotherapy as a treatment for osteosarcoma.
A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study of Nivolumab with Radiation or Nivolumab and Ipilimumab with Radiation for the Treatment of Recurrent or Metastatic Sarcoma of the Bone	Nivolumab with radiation or nivolumab and ipilimumab with radiation	To evaluate the safety and efficacy of nivolumab and radiation, as well as nivolumab, ipilimumab, and radiation, as a treatment for recurrent or metastatic sarcoma of the bone.
Open-Label, Multi-Center, Expanded Access Program to Provide Tisagenlecleucel to Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) CD19+ Acute Lymphoblastic Leukemia (ALL) or r/r CD19+ Diffuse Large B-Cell Lymphoma (DLBCL)	Tisagenlecleucel, a type of immunotherapy	To provide pediatric and young adult patients with relapsed or refractory CD19+ acute lymphoblastic leukemia or CD19+ diffuse large B-cell lymphoma with access to tisagenlecleucel, a type of immunotherapy.

These clinical trials are just a few examples of the ongoing research and development in the field of bone cancer treatment. Participation in clinical trials can provide hope to bone cancer patients and potentially improve outcomes for future patients.

Coping with a Stage 4 Bone Cancer Diagnosis

A stage 4 bone cancer diagnosis can be overwhelming, and it’s normal to feel a range of emotions such as fear, anxiety, and shock. Coping with these feelings is an important part of the healing process. Here are some practical tips and guidance on how to cope:

Talk to Your Healthcare Team

Your healthcare team can help you understand your diagnosis, treatment options, and what to expect. Make sure you ask any questions you may have, and voice your concerns. Knowing what you’re facing can help you feel more in control and prepared.

Lean on Your Support System

It’s important to have a support system throughout your journey. This can be family, friends, support groups, or a counselor. Don’t be afraid to ask for help or express your feelings. Your loved ones want to be there for you.

Take Care of Your Physical Health

Exercise, eat a healthy diet, and get enough rest. A healthy body can help you better manage the physical challenges of treatment and cope with stress.

Take Care of Your Mental Health

It’s normal to feel anxious, depressed or stressed during this time. Consider seeking professional help, such as a therapist or counselor, to help you manage your emotions and work through any challenges you may face.

Stay Positive

Try to focus on positive things in your life and set small goals for yourself. Celebrate your achievements, no matter how small they may seem.

Stay Informed

Stay informed about your diagnosis and treatment options. Read reliable sources of information or ask your healthcare team for reputable resources. Knowing what’s happening can help you feel more in control.

Join a Clinical Trial or Support Group

Clinical trials and support groups can offer you the opportunity to connect with others who are dealing with the same challenges and help you feel less alone. They can also provide access to new treatments or therapies that may offer hope for recovery.

Remember, it’s important to take care of yourself and seek support when you need it. Coping with a stage 4 bone cancer diagnosis can be challenging, but with the right mindset and resources, you can face it with strength and resilience.

Support Networks and Resources

Receiving a stage 4 bone cancer diagnosis can be overwhelming, but you are not alone. There are many support networks and resources available to help you navigate this difficult journey.

The American Cancer Society (ACS) is a non-profit organization that provides a wealth of information and resources for cancer patients. They offer support services, such as transportation assistance, lodging during treatment, and support groups.

The Bone Cancer Research Trust is another organization that provides resources specifically for individuals with bone cancer. They offer online support groups, a helpline, and information on treatments and clinical trials.

Many hospitals and cancer centers also have social workers or patient navigators who can assist you in finding resources and support networks. You can contact your healthcare provider or visit the Association of Cancer Online Resources (ACOR) for a directory of cancer support groups.

It is important to remember that seeking support is not a sign of weakness, but rather a crucial part of coping with a stage 4 bone cancer diagnosis. Reach out to family, friends, or support groups to help you manage the emotional and physical challenges that come with the disease.

FAQ

What is the survival rate of stage 4 bone cancer?

The survival rate of stage 4 bone cancer varies depending on several factors such as the type and location of the cancer, overall health of the patient, and the available treatment options. It is important to consult with a medical professional to discuss individual prognosis and treatment plans.

How does stage 4 bone cancer differ from earlier stages?

Stage 4 bone cancer is characterized by the spread of cancer cells to distant sites in the body, often beyond the primary bone tumor. This advanced stage can make treatment more challenging and impact the overall prognosis of the patient.

What factors can affect the survival rate of stage 4 bone cancer?

Several factors can influence the survival rate of patients with stage 4 bone cancer. These may include the patient’s age, overall health condition, response to treatment, access to healthcare, and the presence of any other underlying medical conditions. Consulting with healthcare professionals can provide a more personalized understanding of individual prognosis.

Are survival rates different for different subtypes of bone cancer?

Yes, the survival rates can vary among the different subtypes of bone cancer. Each subtype has its own characteristics and response to treatment, which can influence the overall prognosis. Accurate diagnosis and a tailored treatment plan are crucial for improving the chances of survival.

What are the treatment options for stage 4 bone cancer?

Treatment options for stage 4 bone cancer may include surgery to remove the tumor and any affected surrounding tissue, chemotherapy to target cancer cells throughout the body, radiation therapy to destroy cancer cells, targeted therapy to specifically attack cancer cells, and immunotherapy to boost the body’s immune system in fighting the cancer. The most suitable treatment plan will depend on the individual’s specific case and should be discussed with a medical professional.

What is the prognosis for stage 4 bone cancer patients?

Prognosis for stage 4 bone cancer patients varies based on individual factors. While stage 4 bone cancer is generally considered to have a lower survival rate compared to earlier stages, advancements in treatments and therapies continue to improve outcomes. Palliative care plays an essential role in managing symptoms and improving the quality of life for patients.

Are there any clinical trials or emerging therapies for stage 4 bone cancer?

Yes, there are ongoing clinical trials and emerging therapies for stage 4 bone cancer. These trials aim to investigate new treatments, therapies, and approaches to improve survival rates and quality of life for patients. It is recommended to consult with healthcare professionals or clinical trial experts to explore potential opportunities.

How can individuals cope with a stage 4 bone cancer diagnosis?

Coping with a stage 4 bone cancer diagnosis can be challenging both emotionally and physically. It is important for individuals to seek support from their loved ones, connect with support groups or counseling services, and prioritize self-care. Engaging in stress-reducing activities, maintaining a positive mindset, and following the guidance of the healthcare team can also aid in coping with the diagnosis.

What support networks and resources are available for stage 4 bone cancer patients?

There are various support networks, organizations, and resources available for individuals with stage 4 bone cancer and their families. These can include patient advocacy organizations, online communities, local support groups, and informational websites. These resources can provide valuable information, emotional support, and practical assistance throughout the journey with stage 4 bone cancer.

Welcome to our comprehensive guide on the treatment options available for stage 3 cervical cancer. In this article, we will explore various approaches to managing this condition, focusing on their effectiveness and benefits. Understanding the treatment landscape is crucial for individuals and their loved ones facing stage 3 cervical cancer, as it empowers them to make informed decisions regarding their care.

Stage 3 cervical cancer is an advanced form of the disease, where cancer cells have spread to nearby tissues and potentially to the lymph nodes. Treatment aims to eradicate or control the cancer, alleviate symptoms, and improve quality of life. It typically involves a combination of different modalities based on the individual’s specific circumstances and medical recommendations.

In the following sections, we will delve into each treatment option, examining its role in addressing stage 3 cervical cancer:

Surgery as a Treatment Option

Surgery plays a crucial role in the treatment of stage 3 cervical cancer. It offers a direct approach to removing cancerous cells and can be used as a standalone treatment or in combination with other therapies. Two primary surgical interventions for stage 3 cervical cancer are radical hysterectomy and lymph node dissection.

Radical Hysterectomy

A radical hysterectomy involves the removal of the cervix, uterus, upper vagina, and surrounding tissues where the cancer may have spread. This procedure is typically performed under general anesthesia and may require a hospital stay of several days. The goal of a radical hysterectomy is to eliminate the tumor and reduce the risk of cancer recurrence.

Lymph Node Dissection

To assess the spread of cancer, lymph node dissection, also known as lymphadenectomy, may be performed during a radical hysterectomy. This procedure involves the removal of pelvic and/or para-aortic lymph nodes for pathological examination. Lymph node dissection helps determine the stage of cancer and guides further treatment decisions.

It is important to note that surgery may not be suitable for all patients with stage 3 cervical cancer. Factors such as overall health, age, and the extent of cancer spread are taken into consideration when determining the most appropriate treatment approach. A comprehensive evaluation by a multidisciplinary team of healthcare professionals helps tailor the treatment plan to individual needs.

Surgical Option	Description
Radical Hysterectomy	Removal of the cervix, uterus, upper vagina, and surrounding tissues
Lymph Node Dissection	Removal of pelvic and/or para-aortic lymph nodes for pathological examination

Radiation Therapy for Stage 3 Cervical Cancer

Radiation therapy plays a crucial role in the treatment of stage 3 cervical cancer. It can be employed as a primary therapy or used alongside other treatment modalities to effectively target cancer cells and reduce tumor size. Radiation therapy utilizes high-energy beams or radioactive sources to destroy cancer cells and prevent their further growth.

Benefits of Radiation Therapy:

• Targets cancer cells in the cervix, uterus, and nearby lymph nodes
• Effective in reducing tumor size and controlling the spread of cancer
• Can be used as a curative treatment option in some cases
• Minimally invasive compared to surgery
• Preserves fertility in select patients

Potential Side Effects:

While radiation therapy is an effective treatment option, it may also have some side effects. These can vary depending on the type and duration of treatment, as well as individual patient factors. Potential side effects of radiation therapy for stage 3 cervical cancer include:

Side Effects	Description
Fatigue	The feeling of physical and mental tiredness
Skin Changes	Redness, dryness, or darkening of the skin in the treatment area
Nausea and Vomiting	The feeling of sickness and involuntary emptying of the stomach
Bladder and Bowel Changes	Increased frequency, urgency, or discomfort during urination or bowel movements
Sexual Dysfunction	Changes in sexual desire or function
Fertility Issues	Possible impact on fertility, depending on treatment approach

It is important to remember that not all patients will experience these side effects, and their severity can vary from person to person. Healthcare providers will closely monitor patients undergoing radiation therapy to manage and alleviate any potential side effects.

Chemotherapy and Its Role in Treating Stage 3 Cervical Cancer

In the treatment of stage 3 cervical cancer, chemotherapy plays a vital role in targeting cancer cells and reducing the risk of recurrence. Administered through various delivery methods, chemotherapy drugs are designed to destroy cancer cells while minimizing damage to healthy tissues.

Chemotherapy can be used as a primary treatment for stage 3 cervical cancer or as an adjuvant therapy after surgery or radiation. It can be delivered in different forms, such as intravenous infusion, oral medication, or directly into the affected area.

One of the primary chemotherapy regimens used for stage 3 cervical cancer is a combination of cisplatin and paclitaxel. These drugs work together to inhibit the growth and division of cancer cells, preventing them from spreading further.

While chemotherapy is effective in treating stage 3 cervical cancer, it can also present certain side effects, which may vary depending on the individual and the specific drugs used. Common side effects include fatigue, nausea, hair loss, and lowered blood cell counts. However, it is essential to note that side effects can be managed with supportive medications and interventions.

In some cases, concurrent chemoradiotherapy may be recommended, where chemotherapy is combined with radiation therapy to enhance treatment outcomes. This multidisciplinary approach aims to boost the effectiveness of both therapies, increasing the chances of successful cancer treatment.

Patients need to discuss chemotherapy treatment options, potential side effects, and supportive care measures with their healthcare team. Understanding the benefits and risks of chemotherapy can help individuals make informed decisions about their treatment plans.

Key Points:

• Chemotherapy is a vital treatment modality for stage 3 cervical cancer.
• It can be used as a primary therapy or in conjunction with surgery or radiation.
• A combination of cisplatin and paclitaxel is commonly used to target cancer cells.
• Side effects of chemotherapy can be managed with supportive care measures.
• Concurrent chemoradiotherapy may be recommended to enhance treatment outcomes.

Targeted Therapy for Stage 3 Cervical Cancer

In the treatment of stage 3 cervical cancer, targeted therapy has emerged as a promising approach. This innovative treatment option aims to selectively target cancer cells while minimizing damage to healthy cells, thereby enhancing the effectiveness of cancer treatment. Targeted therapies for stage 3 cervical cancer primarily involve the use of immune checkpoint inhibitors and angiogenesis inhibitors.

Immune Checkpoint Inhibitors

Immune checkpoint inhibitors are a type of targeted therapy that works by blocking proteins that can prevent the immune system from effectively attacking cancer cells. In stage 3 cervical cancer, immune checkpoint inhibitors such as pembrolizumab and nivolumab have shown promising results in clinical trials, with improved response rates and prolonged survival observed in some patients.

Angiogenesis Inhibitors

Angiogenesis inhibitors are targeted therapies that aim to prevent the formation of new blood vessels, which are crucial for the growth and spread of tumors. By inhibiting angiogenesis, these therapies can effectively reduce the blood supply to cancer cells, thereby restricting their ability to grow and metastasize. Bevacizumab is one such angiogenesis inhibitor that has been studied in the context of stage 3 cervical cancer, demonstrating potential benefits in combination with standard chemotherapy regimens.

Targeted Therapy	Benefits	Potential Side Effects
Immune Checkpoint Inhibitors (e.g., pembrolizumab, nivolumab)	– Enhanced immune response against cancer cells – Improved response rates and survival in some patients	– Fatigue – Rash – Immune-related adverse effects
Angiogenesis Inhibitors (e.g., bevacizumab)	– Reduced blood supply to tumors – Potential benefits in combination with chemotherapy	– High blood pressure – Increased risk of bleeding – Gastrointestinal perforation

It is important to note that targeted therapies for stage 3 cervical cancer are still under investigation, and their precise role in treatment is being defined through ongoing research and clinical trials. Additionally, like any cancer treatment, targeted therapies can have side effects that vary depending on the individual. Therefore, patients must have thorough discussions with their healthcare team to understand the potential benefits, risks, and suitability of targeted therapy as part of their overall treatment plan.

Emerging Therapies for Stage 3 Cervical Cancer

In recent years, there has been significant progress in the development of emerging therapies for stage 3 cervical cancer. Researchers and medical professionals are exploring innovative approaches, such as immunotherapy and gene therapy, to improve treatment outcomes and enhance the quality of life for patients.

Immunotherapy: Harnessing the Power of the Immune System

Immunotherapy has emerged as a promising treatment option for stage 3 cervical cancer. It works by stimulating the patient’s immune system to recognize and attack cancer cells more effectively. This approach has shown encouraging results in clinical trials, with some patients experiencing prolonged survival rates and improved response to treatment.

Gene Therapy: Targeting Cancer at the Molecular Level

Another exciting area of research is gene therapy, which involves introducing genetic material into cancer cells to inhibit their growth or induce cell death. By targeting specific genes or molecular pathways, gene therapy holds the potential to disrupt the mechanisms that allow cancer cells to survive and proliferate. While still in the early stages of development, initial studies have shown promising results in preclinical models.

As research continues to progress, it is important to note that emerging therapies are not yet widely available and may only be accessible through clinical trials or specialized centers. However, these advancements offer hope for future treatment options and underline the ongoing commitment to finding new approaches to combat stage 3 cervical cancer.

Treatment	Potential Benefits	Current Status
Immunotherapy	Enhanced immune response, improved survival rates	Undergoing clinical trials, limited availability
Gene Therapy	Inhibition of cancer cell growth, potential for targeted treatment	Early stages of development, preclinical studies

While emerging therapies hold great promise, it is important to acknowledge that further research and clinical trials are needed to determine their safety and long-term efficacy. Patients need to consult with their healthcare providers to access the most appropriate and up-to-date treatment options for stage 3 cervical cancer.

Clinical Trials and Experimental Treatments

In the quest for innovative and effective treatments for stage 3 cervical cancer, clinical trials play a vital role. These trials, conducted by researchers and healthcare professionals, aim to evaluate the safety and efficacy of experimental treatments. Through participation in clinical trials, patients have the opportunity to access cutting-edge therapies that may otherwise not be available.

Researchers design clinical trials to explore new treatment approaches, refine existing therapies, and uncover potential breakthroughs in cancer management. These trials adhere to strict protocols and guidelines to ensure patient safety and reliable data collection.

In the field of stage 3 cervical cancer, various clinical trials are underway, testing novel treatments and interventions. These trials often involve the use of targeted therapies, immunotherapy agents, and combination therapies to enhance treatment outcomes. By investigating these experimental treatments, researchers aim to advance the understanding of the disease and improve patient outcomes.

Participating in a clinical trial for stage 3 cervical cancer offers several potential benefits. It provides access to innovative treatments before they become widely available, and it allows patients to contribute to the development of improved therapies. Additionally, patients in clinical trials receive close medical supervision and comprehensive care from a multidisciplinary team.

To find clinical trials for stage 3 cervical cancer, patients can consult their healthcare providers or visit reputable online resources, such as the National Cancer Institute’s Clinical Trials Database. These resources provide information about ongoing trials, inclusion criteria, and contact details for trial coordinators.

Ongoing Clinical Trials for Stage 3 Cervical Cancer

Study Title	Treatment Approach	Status
Phase III Trial of Chemotherapy plus Radiation Therapy with or without Bevacizumab in Patients with Locally Advanced Cervical Cancer	Chemotherapy, radiation therapy, bevacizumab (angiogenesis inhibitor)	Ongoing, recruiting participants
Phase II Study of Pembrolizumab (PD-1 Blockade) in Combination with Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer	Pembrolizumab (immune checkpoint inhibitor), chemotherapy	Ongoing, recruiting participants
Phase I Study of Gene Therapy for Locally Advanced Cervical Cancer	Gene therapy	Ongoing, recruiting participants

Note: This table provides a snapshot of ongoing clinical trials for stage 3 cervical cancer and does not represent an exhaustive list. The status of trials may change, and participation criteria may vary. It is advisable to consult healthcare professionals or research coordinators for the most up-to-date information.

Palliative Care and Supportive Treatments

Palliative care and supportive treatments play a critical role in improving the quality of life for individuals with stage 3 cervical cancer. These approaches focus on providing comprehensive care that addresses both physical and emotional needs, aiming to enhance comfort and overall well-being.

Pain Management

Effective pain management is a crucial aspect of palliative care for individuals with stage 3 cervical cancer. This involves a multidisciplinary approach that may include medications, such as opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and antidepressants, as well as interventions like nerve blocks and physical therapy. Specialized techniques like acupuncture and massage therapy can also offer relief and promote relaxation.

Emotional Support

The emotional impact of a stage 3 cervical cancer diagnosis can be overwhelming. Palliative care teams are equipped to provide emotional and psychological support to patients and their families, helping them navigate through the challenges and uncertainties they may face. Supportive therapies such as counseling, support groups, and mindfulness techniques can offer comfort and aid in coping with anxiety, depression, and stress.

Social Support

Social support is vital for individuals with stage 3 cervical cancer to feel connected, acknowledged, and understood. Palliative care teams can help patients and their families access community resources, support groups, and peer networks where they can find solace, share experiences, and gain valuable insights. Encouraging participation in such supportive communities can provide a sense of belonging and foster a positive outlook.

Advance Care Planning

As part of the palliative care approach, individuals with stage 3 cervical cancer are encouraged to engage in advance care planning. This involves open and honest discussions about treatment options, personal values, and goals of care. By proactively addressing end-of-life preferences and documenting healthcare decisions, patients can have peace of mind knowing that their wishes will be respected.

Palliative Care and Supportive Treatments	Benefits
Pain management	Reduced discomfort and improved quality of life
Emotional support	Enhanced psychological well-being and better coping mechanisms
Social support	Increased sense of belonging and a support system for patients and their families
Advance care planning	Ensuring personal values and healthcare decisions are honored

Integrative Medicine and Complementary Therapies

Integrative medicine and complementary therapies play a significant role in supporting individuals during their treatment journey for stage 3 cervical cancer. These approaches focus on enhancing overall well-being and promoting holistic healing, with a particular emphasis on the mind-body connection. By combining conventional medical treatments with evidence-based complementary practices, patients can experience improved quality of life and reduced side effects.

The Role of Integrative Medicine

Integrative medicine encompasses an approach that combines conventional medical treatments with complementary therapies to address the physical, emotional, and spiritual needs of patients. By incorporating practices such as acupuncture, massage therapy, and herbal supplements, integrative medicine aims to enhance the body’s natural healing mechanisms and support the effectiveness of conventional treatments.

Research has shown that integrative medicine can provide numerous benefits for individuals with stage 3 cervical cancer. For example, acupuncture has been found to alleviate chemotherapy-induced nausea and vomiting, while massage therapy can help reduce stress, pain, and anxiety. Additionally, mind-body techniques like yoga and meditation have been shown to improve overall well-being and quality of life.

The Role of Complementary Therapies

Complementary therapies, also known as alternative therapies, work alongside traditional medical treatments to provide additional support and symptom management. These therapies encompass various modalities, including herbal medicine, aromatherapy, and nutritional supplements.

Specific complementary therapies, such as acupuncture and yoga, have gained recognition for their potential benefits in managing side effects and improving overall outcomes for individuals with stage 3 cervical cancer. Acupuncture can help alleviate pain, reduce fatigue, and improve sleep quality. Yoga, on the other hand, promotes flexibility, reduces stress, and enhances emotional well-being.

Collaborative Care and Consultation

It is essential for individuals considering integrative medicine and complementary therapies to work closely with their healthcare team. Open communication and collaboration between healthcare providers and complementary therapy practitioners ensure that all aspects of the patient’s care are coordinated and aligned to optimize treatment outcomes.

Patients should consult with their oncologists and other healthcare professionals before incorporating any complementary therapies into their treatment plans. This collaboration helps to ensure the safe and effective integration of complementary therapies into the overall care strategy.

The Table below provides an overview of common integrative medicine and complementary therapies used in the treatment of stage 3 cervical cancer:

Integrative Medicine	Complementary Therapies
Acupuncture	Herbal medicine
Mind-body techniques (yoga, meditation)	Aromatherapy
Massage therapy	Nutritional supplements

Psychological Support and Counseling

Psychological support and counseling play a crucial role in the comprehensive care of individuals with stage 3 cervical cancer. Coping with a cancer diagnosis and undergoing treatment can lead to increased emotional distress and mental health challenges. Access to professional psychological support and counseling services can help individuals navigate these difficult emotions, manage stress, and promote overall well-being.

Psychological support services provide a safe and confidential space for individuals to express their fears, anxieties, and concerns about their condition. These services are delivered by qualified mental health professionals who specialize in providing emotional support to cancer patients. The goal is to help patients develop coping strategies and tools to navigate the emotional impact of their diagnosis and treatment.

Counseling sessions can address a range of psychological and emotional issues, including anxiety, depression, grief, body image concerns, and relationship difficulties. Additionally, counseling can help individuals develop effective communication and coping skills, build resilience, and foster a positive mindset during their cancer journey.

The Benefits of Psychological Support and Counseling

The benefits of psychological support and counseling for individuals with stage 3 cervical cancer are numerous. Here are some key benefits:

• Helps manage anxiety and depression associated with a cancer diagnosis
• Provides a supportive environment to express fears, concerns, and emotions
• Assists in developing effective coping strategies for managing stress
• Improves overall emotional well-being and quality of life
• Enhances communication skills with healthcare providers, family, and friends
• Promotes a positive mindset and resilience

It is important to note that psychological support and counseling should be tailored to the individual’s specific needs and preferences. This may include individual counseling sessions, group therapy, or a combination of both. The frequency and duration of counseling sessions may vary depending on the individual’s requirements and treatment plan.

By addressing the emotional aspects of living with stage 3 cervical cancer, psychological support, and counseling can significantly improve the overall well-being and quality of life for individuals facing this challenging disease.

Overview of Psychological Support and Counseling Services

Services	Description
Individual Counseling	One-on-one sessions with a qualified mental health professional to address specific emotional needs and concerns.
Group Therapy	Participation in group sessions with other individuals facing similar challenges, providing a supportive and understanding environment.
Family Counseling	Sessions that involve family members to improve communication, address relationship issues, and strengthen support networks.
Support Groups	Facilitated gatherings where individuals can share experiences, gain practical advice, and find comfort in a community of peers.
Cognitive-Behavioral Therapy	A type of therapy that focuses on identifying and changing negative thought patterns and behaviors to promote emotional well-being.

Support Groups and Peer Networks

Support groups and peer networks play a crucial role in the journey of individuals affected by stage 3 cervical cancer. These communities provide a sense of belonging, understanding, and empathy, helping patients, survivors, and their loved ones navigate the challenges associated with the disease.

When facing a diagnosis of stage 3 cervical cancer, it is common to feel overwhelmed and isolated. Joining a support group can help alleviate these feelings by connecting individuals going through similar experiences. In these groups, participants can share their stories and emotions, finding solace in the support and understanding of others who truly comprehend the physical and emotional impact of the condition.

Support groups offer a safe space for individuals to express their fears, anxieties, and triumphs while receiving encouragement and guidance. Participants often develop strong bonds and lifelong friendships through these shared experiences. Members uplift each other, providing a network of emotional support during every stage of the cancer journey.

Additionally, support groups provide practical advice and valuable insights. Members can exchange information about treatment options, coping strategies, and helpful resources, allowing individuals to make more informed decisions about their care and well-being. Peer networks offer a diverse range of perspectives and experiences, enabling participants to benefit from a wealth of knowledge.

Benefits of Support Groups and Peer Networks:

• Emotional Support: Individuals can share their thoughts and feelings, receive encouragement, and gain a sense of belonging from others who understand their challenges.
• Practical Advice and Information: Support groups offer a platform for members to exchange knowledge about treatment options, managing side effects, and accessing supportive resources.
• Shared Experiences: Participants can connect with others facing similar journeys, fostering a sense of camaraderie and understanding that is crucial for overall well-being.
• Promoting Mental Health: Peer networks provide opportunities for individuals to discuss the emotional impact of the disease and learn coping strategies to navigate the psychological challenges.
• Building Resilience and Empowerment: Support from peers can help individuals build resilience, regain a sense of control, and feel empowered throughout their cancer experience.

In conclusion, support groups and peer networks form an invaluable part of the comprehensive care and support system for those affected by stage 3 cervical cancer. These communities not only provide emotional support but also offer practical advice, shared experiences, and a sense of empowerment. By fostering a strong network of support, individuals facing stage 3 cervical cancer can find comfort, knowledge, and the strength to navigate their journey with confidence.

Lifestyle Factors and Recommendations

Adopting a healthy lifestyle can play a crucial role in improving treatment outcomes for individuals with stage 3 cervical cancer. Making positive changes in diet, exercise, and stress management can have a significant impact on overall well-being and aid in the healing process.

Dietary Recommendations

A well-balanced diet rich in nutrients can help support the immune system and contribute to better treatment response. Here are some dietary recommendations for individuals with stage 3 cervical cancer:

• Focus on consuming a variety of fruits and vegetables that are high in antioxidants, vitamins, and minerals.
• Incorporate whole grains, lean proteins, and healthy fats into your meals.
• Avoid processed foods, sugary snacks, and excessive intake of red and processed meats.
• Stay hydrated by drinking an adequate amount of water throughout the day.

Exercise Tips

Maintaining an active lifestyle can offer numerous benefits during cancer treatment, including improved mood, increased energy levels, and enhanced overall physical well-being. It is essential to consult with your healthcare team before starting any exercise regimen. Here are some exercise tips:

• Engage in regular moderate-intensity exercises such as brisk walking, swimming, or cycling.
• Consider incorporating strength training exercises to improve muscle strength and flexibility.
• Listen to your body and adjust the intensity and duration of exercise based on your energy levels and physical capabilities.

Stress Management Strategies

Chronic stress can hurt both physical and mental health. Incorporating effective stress management strategies can help reduce anxiety, improve sleep quality, and enhance overall well-being. Here are some recommendations:

• Practice relaxation techniques such as deep breathing exercises, meditation, or yoga.
• Find activities that bring you joy and help you relax, such as engaging in hobbies, listening to music, or spending time in nature.
• Seek support from friends, family, or professional counselors to help manage emotional stressors.

By implementing these lifestyle factors and recommendations, individuals with stage 3 cervical cancer can strive for a healthier and more balanced life, complementing their medical treatment and improving their overall well-being.

Lifestyle Factors	Recommendations
Diet	Include a variety of fruits, vegetables, whole grains, lean proteins, and healthy fats in your diet. Avoid processed foods, sugary snacks, and excessive intake of red and processed meats.
Exercise	Engage in regular moderate-intensity exercises such as brisk walking, swimming, or cycling. Consider incorporating strength training exercises to improve muscle strength and flexibility.
Stress Management	Practice relaxation techniques such as deep breathing exercises, meditation, or yoga. Find activities that bring you joy and help you relax. Seek support from friends, family, or professional counselors.

Follow-Up Care and Survivorship

After completing treatment for stage 3 cervical cancer, individuals must prioritize long-term follow-up care and survivorship plans. These crucial aspects play a significant role in monitoring potential recurrent or new cancer developments, managing late effects, and ensuring overall well-being.

Regular surveillance is essential for detecting any signs of cancer recurrence promptly. Follow-up care typically involves scheduled appointments with healthcare professionals, including gynecologic oncologists, oncology nurses, and radiation oncologists. These visits may include physical examinations, imaging tests such as CT scans or MRIs, and bloodwork to assess tumor markers or other relevant indicators.

Aside from monitoring for cancer recurrence, survivorship care also focuses on managing potential late effects of treatment. Depending on the specific treatments received, individuals may experience side effects such as lymphedema, early menopause, sexual dysfunction, or emotional challenges. Healthcare providers will offer guidance and support to address these concerns, ensuring optimal survivorship and quality of life.

In addition to medical care, survivorship plans also emphasize healthy lifestyle choices. This may include recommendations for a balanced diet, regular exercise, and stress reduction strategies. Adopting these practices can help improve overall well-being and reduce the risk of cancer recurrence or other health complications.

FAQ

What are the treatment options for stage 3 cervical cancer?

The treatment options for stage 3 cervical cancer may include surgery, radiation therapy, chemotherapy, targeted therapy, and emerging therapies. The choice of treatment depends on various factors, such as the extent of the cancer, overall health, and personal preferences.

What is the role of surgery in treating stage 3 cervical cancer?

Surgery can be a treatment option for stage 3 cervical cancer and may involve procedures like radical hysterectomy and lymph node dissection. These surgeries aim to remove the cancerous cells and nearby lymph nodes to prevent the spread of the disease.

How is radiation therapy used in the management of stage 3 cervical cancer?

Radiation therapy can be used as a primary treatment or in combination with other modalities for stage 3 cervical cancer. It involves the use of high-energy rays to kill cancer cells or shrink tumors. Radiation therapy can be delivered externally or internally through brachytherapy.

What is the role of chemotherapy in treating stage 3 cervical cancer?

Chemotherapy drugs can be administered to individuals with stage 3 cervical cancer either alone or in conjunction with other treatments like surgery or radiation therapy. Chemotherapy aims to destroy cancer cells or impede their growth, often using a combination of drugs.

What is targeted therapy, and how does it relate to stage 3 cervical cancer?

Targeted therapy is a treatment approach that focuses on specific molecules or pathways involved in the growth of cancer cells. In the case of stage 3 cervical cancer, targeted therapy options like immune checkpoint inhibitors and angiogenesis inhibitors can be used to disrupt the growth and spread of cancer cells.

Are there any emerging therapies being studied for stage 3 cervical cancer?

Yes, researchers are exploring new treatment approaches, including immunotherapy and gene therapy, for the management of stage 3 cervical cancer. These emerging therapies hold promise in enhancing treatment outcomes and expanding the treatment options available.

What role do clinical trials play in the treatment of stage 3 cervical cancer?

Clinical trials are vital in advancing the understanding and treatment of stage 3 cervical cancer. They provide opportunities for individuals to access experimental treatments and contribute to the development of future therapies. Participation in clinical trials is voluntary and usually guided by eligibility criteria.

How do palliative care and supportive treatments benefit individuals with stage 3 cervical cancer?

Palliative care and supportive treatments play a crucial role in improving the quality of life for individuals with stage 3 cervical cancer. These services focus on addressing pain, managing symptoms, and providing emotional and psychological support throughout the treatment journey.

What is integrative medicine, and how does it complement conventional treatments for stage 3 cervical cancer?

Integrative medicine integrates complementary therapies, such as acupuncture and yoga, with conventional medical treatments. It aims to enhance overall well-being and may help manage treatment-related side effects, reduce stress, and improve the overall treatment experience for individuals with stage 3 cervical cancer.

Why is psychological support and counseling important for individuals with stage 3 cervical cancer?

Psychological support and counseling services are essential for individuals with stage 3 cervical cancer as they provide a safe space for emotional expression and help individuals cope with the challenges associated with the disease. These services can significantly impact mental well-being and overall treatment outcomes.

How can support groups and peer networks assist individuals affected by stage 3 cervical cancer?

Support groups and peer networks offer a sense of community, provide shared experiences, and offer practical advice for individuals affected by stage 3 cervical cancer. They can act as a valuable source of support, guidance, and inspiration throughout the treatment journey.

What lifestyle factors can enhance treatment outcomes for individuals with stage 3 cervical cancer?

Adopting a healthy lifestyle can have a positive impact on treatment outcomes for individuals with stage 3 cervical cancer. This may include following a balanced diet, engaging in regular exercise, managing stress, and avoiding harmful habits like smoking.

Why is follow-up care and survivorship important for individuals who have completed treatment for stage 3 cervical cancer?

Follow-up care and survivorship plans are crucial for individuals who have completed treatment for stage 3 cervical cancer. They involve regular check-ups, surveillance for potential recurrence or late effects, and ongoing support to ensure the long-term well-being and overall health of the patient.

Welcome to our comprehensive guide on transurethral resection of bladder tumor (TURBT), a highly effective procedure for treating bladder cancer. Bladder cancer is a type of malignancy that affects the bladder, a vital organ responsible for storing urine. TURBT, also known as transurethral bladder tumor resection, is a minimally invasive surgical technique used to remove bladder tumors.

Bladder tumors are abnormal growths that develop in the tissue lining the inside of the bladder. If left untreated, these tumors can lead to serious health complications. TURBT offers a promising solution for bladder cancer patients, providing a highly targeted approach to removing tumors while preserving bladder function.

During a TURBT procedure, a urologist uses a special instrument called a resectoscope to remove the tumor from the bladder. This procedure offers several advantages, including the ability to examine the tumor and surrounding tissue under a microscope for accurate diagnosis, as well as the ability to remove tumors without making large incisions.

In this article, we will explore various aspects of transurethral resection of bladder tumors, including its benefits, the diagnosis of bladder cancer, the preparation for the TURBT procedure, the procedure itself, anesthesia options, and potential risks and complications. We will also discuss the recovery process, follow-up care, adjuvant treatment options, and the long-term outlook for patients who undergo TURBT.

Bladder cancer is a serious condition that requires timely and comprehensive treatment. If you or someone you know has been diagnosed with bladder cancer, understanding the options available, such as transurethral resection of a bladder tumor, can help make informed decisions and improve the chances of successful treatment. Let’s delve deeper into this innovative procedure and its role in combating bladder cancer.

Understanding Bladder Cancer

Bladder cancer is a malignant condition that originates in the cells of the bladder. It is one of the most common types of cancer, with thousands of new cases diagnosed each year.

Causes:
The exact cause of bladder cancer is not fully understood, but several risk factors have been identified. These include smoking, exposure to certain chemicals and toxins, chronic bladder inflammation, and genetic factors.

Symptoms:
Bladder cancer presents with various symptoms, including blood in the urine (hematuria), frequent urination, pain during urination, and lower back pain. However, it is important to note that these symptoms can also be caused by other conditions, so proper diagnosis is essential.

Prevalence:
Bladder cancer affects both men and women, but it is more common in men. According to the American Cancer Society, bladder cancer is the fourth most common cancer in men and the ninth most common in women in the United States.

Common Symptoms of Bladder Cancer

Symptoms	Description
Blood in the urine (hematuria)	One of the most common signs of bladder cancer. It may be visible to the naked eye or detected during urinalysis.
Frequent urination	Feeling the need to urinate more often than usual, even with small amounts of urine.
Pain during urination	Experiencing discomfort or a burning sensation while passing urine.
Lower back pain	Unexplained pain in the lower back, often experienced on one side.

To effectively treat bladder cancer, early detection and intervention are crucial. Transurethral resection of bladder tumor (TURBT) is a commonly used surgical procedure that plays a vital role in the management of bladder cancer. In the following sections, we will delve into the diagnosis, treatment, and recovery process associated with bladder cancer and TURBT.

Diagnosis of Bladder Cancer

Early diagnosis of bladder cancer is crucial for effective treatment and improved prognosis. Doctors employ a combination of diagnostic methods to accurately detect bladder cancer. These methods include:

• Cystoscopy: A procedure in which a thin, flexible tube with a camera is inserted into the bladder through the urethra. This allows the doctor to visually examine the bladder for any abnormalities or tumors.
• Imaging Tests: Imaging tests such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) may be used to assess the extent and spread of the cancer.
• Urine Tests: Urine tests, such as urine cytology and urine-based biomarker tests, can help identify abnormal cells or specific molecular markers that indicate the presence of bladder cancer.

The combination of these diagnostic methods allows healthcare professionals to accurately diagnose bladder cancer and determine the best course of treatment. Early detection increases the chances of successful treatment outcomes and improves overall prognosis.

Diagnostic Method	Description
Cystoscopy	A procedure involving the insertion of a thin tube with a camera into the bladder to visualize any abnormalities or tumors.
Imaging Tests	Non-invasive imaging techniques such as ultrasound, CT scans, and MRI aid in assessing the extent and spread of bladder cancer.
Urine Tests	Laboratory tests, including urine cytology and biomarker analysis, to identify abnormal cells or molecular markers associated with bladder cancer.

Introduction to Transurethral Resection of Bladder Tumor

Transurethral resection of bladder tumor (TURBT) is a common surgical procedure used for the treatment of bladder tumors, particularly those that are non-invasive or only slightly invasive. This minimally invasive procedure involves the removal of bladder tumors using a resectoscope, a specialized instrument inserted through the urethra.

TURBT is considered the gold standard for diagnosing and treating bladder tumors, as it allows for both diagnosis and treatment in a single procedure. It is performed under general or spinal anesthesia and typically does not require any external incisions, resulting in shorter hospital stays and faster recovery times for patients.

The TURBT Procedure

The TURBT procedure involves several key steps:

1. Patient preparation: Before the procedure, the patient may need to undergo various tests, including blood work and imaging scans, to assess their overall health and the extent of the bladder tumor.
2. Anesthesia administration: The patient is given anesthesia to ensure their comfort during the procedure. The type of anesthesia used may vary depending on the patient’s health, preferences, and the surgeon’s recommendations.
3. Tumor identification: The surgeon inserts a cystoscope into the bladder through the urethra to visualize the tumor. A cystoscope is a thin tube with a light and a camera on the end, allowing the surgeon to see the tumor on a monitor.
4. Tumor resection: Using a resectoscope with a wire loop or electrocautery device, the surgeon carefully removes the tumor or tumors from the bladder wall. The resectoscope can also be used to cauterize any bleeding vessels.
5. Tissue sampling: Once the tumor is removed, the surgeon may collect tissue samples for further analysis to determine the tumor’s stage and grade.
6. Bladder irrigation: After the tumor removal, the bladder is irrigated with a solution to remove any remaining tumor fragments and blood.
7. Post-operative care: The patient is closely monitored in the recovery room and may be discharged on the same day or the following day, depending on their condition. They will receive instructions on post-operative care, including medication management and when to follow up with their healthcare provider.

By removing the tumor and obtaining tissue samples for analysis, TURBT helps in the accurate diagnosis, staging, and grading of bladder tumors. It also allows for the removal of small tumors and superficial layers of larger tumors, reducing the risk of tumor recurrence.

TURBT Advantages	TURBT Considerations
Effective removal of bladder tumors Diagnosis and treatment in a single procedure Minimal invasiveness Shorter hospital stays Faster recovery times	May not be suitable for larger or invasive bladder tumors May require repeat procedures for recurrent tumors Risk of bleeding, infection, and bladder perforation

Patients need to discuss their specific case with their healthcare provider to determine if TURBT is the most appropriate treatment option for their bladder tumor.

Preparing for Transurethral Resection of Bladder Tumor

Before undergoing transurethral resection of bladder tumor (TURBT), patients need to follow specific preparations. This ensures a smooth and successful surgical experience. The preparations typically involve medical evaluations, lifestyle changes, and medication instructions.

Medical Evaluations

Patients scheduled for TURBT will undergo various medical evaluations to assess their overall health and suitability for the procedure. These evaluations may include:

• Physical examination: A thorough examination by a healthcare professional to evaluate the patient’s general health and identify any pre-existing conditions.
• Laboratory tests: Blood and urine tests may be conducted to assess kidney function, blood counts, and overall health status before surgery.
• Imaging tests: Depending on the individual case, additional imaging tests such as ultrasound, CT scans, or MRI scans may be ordered to evaluate the bladder tumor and surrounding structures.

Lifestyle Changes

Preparing for TURBT also involves making certain lifestyle changes to optimize the surgical outcome. These changes may include:

• Smoking cessation: Patients who smoke are advised to quit smoking to reduce the risk of complications during and after surgery.
• Dietary modifications: Following a healthy and balanced diet rich in fruits, vegetables, and lean proteins can help boost the immune system and promote healing.
• Exercise routine: Engaging in regular physical activity, as approved by the healthcare provider, can improve overall fitness and aid in a faster recovery post-surgery.

Medication Instructions

Patients will receive specific instructions regarding medication management in the period leading up to TURBT. These instructions may include:

• Discontinuation of certain medications: Patients may be advised to temporarily discontinue the use of blood-thinning medications or herbal supplements that can increase the risk of bleeding during surgery.
• Adjustment of current medications: Patients may need to adjust the dosage or timing of certain medications to ensure their safety and optimize surgical outcomes. It is important to follow the healthcare provider’s advice in this regard.
• New medication prescriptions: Based on individual needs, the healthcare provider may prescribe medications to prepare the bladder for surgery or to prevent urinary tract infections.

By carefully following the necessary preparations, patients can help improve the effectiveness and safety of transurethral resection of bladder tumors. These preparations help create a favorable environment for successful bladder tumor surgery, maximizing the chances of a positive outcome.

The TURBT Procedure

Transurethral resection of bladder tumor (TURBT) is a surgical procedure used to remove bladder tumors. It is a minimally invasive approach that offers several benefits, including faster recovery times and reduced risk of complications.

Step-by-step process of the TURBT procedure:

1. Patient Preparation: The patient is positioned on a surgical table, and anesthesia is administered to ensure comfort throughout the procedure.
2. Cystoscopy: A cystoscope, a thin tube with a light and camera at the end, is inserted through the urethra into the bladder. This allows the surgeon to visualize the tumor and surrounding tissue.
3. Tumor Resection: A resectoscope, a specialized instrument with a wire loop, is then used to remove the tumor. The loop is carefully passed through the cystoscope and cuts the tumor away from the bladder wall.
4. Tissue Sampling: Once the tumor is removed, small tissue samples may be taken for biopsy to determine the type and stage of cancer.
5. Cauterization: After the tumor is removed, any bleeding vessels are cauterized, or sealed, to prevent excessive bleeding.
6. Irrigation: The bladder is then irrigated with a saline solution to flush out any remaining tissue or blood.
7. Stent Placement (if necessary): In some cases, a stent may be placed temporarily to ensure proper urine flow and prevent blockages during the healing process.
8. Removal of Instruments: The cystoscope and resectoscope are carefully removed from the urethra, and the procedure is complete.

Overall, the TURBT procedure allows for targeted removal of bladder tumors while preserving bladder function. It is an effective treatment option for many bladder cancer patients.

Advantages of TURBT	Disadvantages of TURBT
– Minimally invasive procedure	– Potential for tumor recurrence
– Shorter recovery time compared to open surgery	– Risk of bleeding and infection
– Preserves bladder function	– Possibility of bladder perforation
– Provides tissue samples for biopsy	– Temporary need for urinary catheter or stent

Anesthesia Options for TURBT

During transurethral resection of bladder tumors (TURBT), different types of anesthesia can be used to ensure patient comfort and safety throughout the procedure. The choice of anesthesia depends on various factors, including the patient’s medical condition, the complexity of the surgery, and the surgeon’s recommendation.

1. Local Anesthesia:

Local anesthesia involves the injection of medication to numb a specific area or region of the body. In the case of TURBT, local anesthesia can be administered to the urinary tract, providing pain relief during the procedure. This type of anesthesia allows the patient to remain awake and aware during the surgery, without feeling pain.

2. Spinal Anesthesia:

Spinal anesthesia is an option for TURBT that involves the injection of anesthesia medication into the fluid surrounding the spinal cord. This results in temporary numbness in the lower body, allowing the patient to remain conscious but free from pain. Spinal anesthesia is particularly useful for longer surgeries or when multiple procedures are performed at the same time.

3. General Anesthesia:

General anesthesia is often used for more complex or prolonged TURBT surgeries. It involves the administration of medication that induces a state of unconsciousness, ensuring that the patient feels no pain or discomfort during the procedure. General anesthesia requires careful monitoring of vital signs by an anesthesiologist to ensure the patient’s safety and optimal surgical conditions.

Each type of anesthesia has its advantages and considerations. Local anesthesia is minimally invasive, avoids potential side effects associated with general anesthesia, and allows for a faster recovery. Spinal anesthesia provides effective pain relief and can be combined with sedation for increased patient comfort. General anesthesia ensures complete unconsciousness and pain control during surgery.

The choice of anesthesia for TURBT is made by the healthcare team based on the patient’s medical history, surgical requirements, and the expertise of the anesthesia provider. Before undergoing TURBT, patients will discuss with their healthcare team to determine the most suitable anesthesia option for their specific situation.

Potential Risks and Complications of TURBT

Transurethral resection of bladder tumor (TURBT) is a commonly performed procedure for the treatment of bladder cancer. While it offers numerous benefits, it is important to be aware of the potential risks and complications associated with this surgery.

Bleeding:

• TURBT can cause bleeding, both during and after the procedure. In some cases, patients may experience blood in their urine for a few days following surgery.
• Significant bleeding may require further medical intervention, such as bladder irrigation or blood transfusion.

Infection:

• There is a risk of infection following TURBT, especially if proper precautions are not taken.
• Patients may be prescribed antibiotics to prevent infection.
• It is important to report any signs of infection, such as increased pain, fever, or urinary tract symptoms.

Bladder Perforation:

• In rare cases, TURBT can result in bladder perforation, which is a hole in the bladder wall.
• This complication may require surgical repair.
• Bladder perforation can cause urine leakage, infection, and other complications.

Urinary Retention:

• Following TURBT, some patients may experience difficulty in emptying their bladder.
• Temporary urinary retention can occur due to swelling or spasms of the bladder.
• In some cases, a urinary catheter may be temporarily inserted to aid in emptying the bladder.

Other Potential Complications:

• Scar tissue formation in the bladder may cause bladder contracture, leading to urinary flow problems.
• There is a risk of damage to surrounding structures, such as the urethra or ureter.
• Rarely, TURBT can result in complications like blood clots, urinary incontinence, or erectile dysfunction.

Patients need to discuss these potential risks and complications with their healthcare provider before undergoing TURBT. While the benefits of TURBT in treating bladder cancer are significant, a thorough understanding of the procedure and its potential risks is crucial for informed decision-making.

Recovery Process After TURBT

After undergoing transurethral resection of bladder tumor (TURBT), the recovery phase plays a crucial role in ensuring a successful outcome. This section provides guidance on the postoperative care and recovery process for patients who have undergone this procedure. It covers important aspects such as pain management, catheter use, and resuming normal activities.

1. Pain Management

Pain management is a key consideration during the recovery period. Following TURBT, it is common to experience some discomfort or pain in the lower abdomen or urinary tract. Your healthcare team will provide appropriate pain relief medication to ensure your comfort and manage any postoperative pain.

2. Urinary Catheter

During the recovery process, you may have a urinary catheter in place. This catheter allows your body to heal by diverting urine away from the surgical site. Your healthcare team will guide the proper care and management of the catheter, including instructions for cleaning and preventing infection. It is important to follow these guidelines carefully for optimal recovery.

3. Monitoring and Follow-Up

Your healthcare team will schedule regular follow-up appointments to monitor your progress and ensure that you are healing well. These appointments may include physical examinations, urine tests, and imaging tests to assess the bladder and monitor for any signs of recurrence. It is crucial to attend these appointments and communicate any concerns or symptoms you may experience.

4. Resuming Normal Activities

As you progress through the recovery phase, your healthcare team will guide you when it is appropriate to resume normal activities. This may include recommendations for gradually increasing physical activity, returning to work, and resuming hobbies or exercise. It is important to follow these instructions to promote healing and avoid complications.

5. Support and Rehabilitation

During the recovery process, it is normal to experience physical and emotional challenges. The support of your healthcare team, as well as friends and family, can greatly contribute to your overall well-being. Additionally, if needed, your healthcare team may recommend resources or rehabilitation programs to assist with recovery, including physical therapy or counseling services.

Recovery Process After TURBT	Key Points
Pain Management	– Ensure proper pain relief medication – Communicate any discomfort or pain to your healthcare team
Urinary Catheter	– Follow the care instructions provided by your healthcare team – Prevent infection through proper catheter hygiene
Monitoring and Follow-Up	– Attend regular follow-up appointments to assess healing and detect any signs of recurrence – Communicate any concerns or symptoms
Resuming Normal Activities	– Gradually increase physical activity as advised – Follow guidelines for returning to work and hobbies
Support and Rehabilitation	– Seek support from the healthcare team, friends, and family – Access resources or rehabilitation programs if needed

Follow-Up Care and Monitoring

After undergoing transurethral resection of a bladder tumor (TURBT), regular follow-up care and monitoring are crucial for the long-term management of bladder cancer. This includes close surveillance to detect any potential recurrences or the development of new tumors.

Patients who have undergone TURBT should schedule regular check-ups with their healthcare provider to monitor their progress and ensure any changes in their condition are promptly addressed. These follow-up appointments typically include:

• Physical examination to assess overall health and any signs of tumor recurrence
• Cystoscopy, is a procedure that allows the doctor to visually inspect the inside of the bladder using a thin tube-like instrument called a cystoscope
• Urine tests to check for any abnormalities or the presence of cancer cells
• Imaging tests such as CT scans or ultrasounds to evaluate the bladder and surrounding structures for any signs of cancer recurrence or metastasis

During the follow-up period, patients should also be vigilant about reporting any symptoms or changes they experience, such as blood in the urine, increased frequency of urination, or pain. Early detection of recurrent tumors is essential for ensuring timely intervention and optimal treatment outcomes.

Furthermore, healthcare providers may recommend additional adjuvant treatments, such as intravesical chemotherapy or immunotherapy, as a preventive measure to reduce the risk of tumor recurrence. These treatments are often administered directly into the bladder to target any residual cancer cells and enhance the chances of long-term remission.

In conclusion, TURBT follow-up and bladder tumor surveillance play a vital role in the ongoing management of bladder cancer. Regular check-ups and monitoring enable early detection of recurrences or new tumors, allowing for timely interventions and improved treatment outcomes.

Adjuvant Treatment Options

After undergoing transurethral resection of bladder tumor (TURBT), patients may require additional therapies to prevent tumor recurrence and improve long-term outcomes. Adjuvant treatment options, such as intravesical chemotherapy and immunotherapy, are commonly recommended as part of a comprehensive bladder cancer treatment plan.

Intravesical chemotherapy: This adjuvant treatment involves the placement of anti-cancer drugs directly into the bladder, where the tumor is removed. The chemotherapy drugs target any remaining cancer cells and help prevent their growth and spread. Commonly used drugs include mitomycin-C and Bacillus Calmette-Guérin (BCG), an immunotherapy drug that also stimulates the immune system.

Immunotherapy: Immunotherapy harnesses the power of the patient’s immune system to recognize and attack cancer cells. One commonly used immunotherapy drug for bladder cancer is BCG, which stimulates an immune response in the bladder. BCG is administered via intravesical installation, directly into the bladder, after TURBT. Other immunotherapy drugs, such as pembrolizumab and atezolizumab, may be used in certain cases.

Comparing Intravesical Chemotherapy and Immunotherapy for Adjuvant Treatment

Treatment	Benefits	Considerations
Intravesical Chemotherapy	Targets remaining cancer cells in the bladder Reduces the risk of tumor recurrence	Potential for side effects, such as bladder irritation May require multiple treatment sessions
Immunotherapy (BCG)	Activates the immune system to fight cancer cells Reduces the risk of tumor recurrence and progression	Potential for side effects, such as flu-like symptoms and bladder irritation Requires careful monitoring for potential BCG-related complications

Patients need to discuss the potential benefits and considerations of these adjuvant treatments with their healthcare team. The choice of treatment will depend on various factors, including the stage and grade of the tumor, the overall health of the patient, and their individual preferences.

Potential Side Effects and Long-Term Implications

Transurethral resection of bladder tumor (TURBT) is an effective procedure for treating bladder cancer. However, like any surgical intervention, it may have potential side effects and long-term implications that patients should be aware of.

Urinary Incontinence

One potential side effect of TURBT is urinary incontinence, which is the involuntary leakage of urine. This can occur due to damage to the urinary sphincter muscles during the surgery. While this side effect is generally temporary, some patients may experience long-term or permanent urinary incontinence.

Erectile Dysfunction

In male patients, TURBT surgery may lead to erectile dysfunction, the inability to achieve or maintain an erection sufficient for sexual activity. This can happen if the nerves responsible for erection are damaged during the procedure. The likelihood of experiencing erectile dysfunction depends on various factors, including the extent of the surgery and the individual’s overall health.

Impact on Fertility

For patients who wish to have children in the future, TURBT surgery may have implications on fertility. In some cases, the removal of bladder tumors may require the removal of a portion of the bladder, which can affect the storage and passage of urine. This may impact fertility, particularly if the surgery involves the removal of reproductive organs or nearby structures.

Other Side Effects

In addition to urinary incontinence, erectile dysfunction, and impacts on fertility, other potential side effects of TURBT surgery may include:

• Bleeding
• Infection
• Bladder spasms
• Urinary tract infections
• Scarring

Patients need to discuss these potential side effects and long-term implications with their healthcare team. Each individual’s experience may vary, and healthcare professionals can provide personalized information and guidance based on the patient’s specific situation.

Side Effect	Description
Urinary Incontinence	Involuntary leakage of urine
Erectile Dysfunction	Inability to achieve or maintain an erection
Impact on Fertility	Implications on reproductive capacity
Bleeding	Excessive or prolonged bleeding
Infection	Infection at the surgical site or in the urinary tract
Bladder spasms	Involuntary contractions of the bladder
Urinary tract infections	Infections affecting the urinary system
Scarring	Formation of scar tissue in the bladder

TURBT Success Rates and Prognosis

Transurethral resection of bladder tumor (TURBT) is a widely used procedure for treating bladder cancer. The success rates and prognosis associated with TURBT can vary depending on several factors, including the stage and grade of the tumor.

Factors Influencing Success Rates

Stage of the Tumor: The stage of the tumor at the time of TURBT plays a crucial role in determining the success rates. Earlier-stage tumors have better outcomes compared to advanced-stage tumors.

Grade of the Tumor: The grade of the tumor, which is an indicator of its aggressiveness, also influences the success rates. Low-grade tumors generally have higher success rates than high-grade tumors.

Complete Removal of the Tumor: The ability to completely remove the tumor during TURBT is essential for achieving successful outcomes. If any cancerous cells are left behind, it can lead to recurrence or progression of the disease.

Prognosis After TURBT

The prognosis after TURBT depends on various factors, such as the stage and grade of the tumor, as well as the patient’s overall health and response to treatment.

Tumor Stage: The stage of the tumor is a critical prognostic factor. Early-stage tumors have better prognoses, with higher chances of successful treatment and long-term survival. Advanced-stage tumors may have a lower prognosis due to a higher risk of recurrence or metastasis.

Tumor Grade: The grade of the tumor also affects the prognosis. Low-grade tumors tend to have a more favorable prognosis compared to high-grade tumors.

Response to Treatment: How well a patient responds to TURBT and any subsequent treatments can impact the prognosis. Adequate response to treatment increases the likelihood of disease control and improves long-term outcomes.

Overall Health: The patient’s overall health, including any pre-existing medical conditions, can influence the prognosis. Good overall health and well-being may enhance the success of the treatment and contribute to better long-term outcomes.

TUMBT Success Rates and Prognosis	Factors Influencing Success Rates
Stage of the Tumor	Earlier-stage tumors have better outcomes compared to advanced-stage tumors.
Grade of the Tumor	Low-grade tumors generally have higher success rates than high-grade tumors.
Complete Removal of the Tumor	The ability to completely remove the tumor during TURBT is essential for achieving successful outcomes.

Alternative Treatment Options for Bladder Cancer

When it comes to bladder cancer, transurethral resection of bladder tumor (TURBT) is a common surgical option. However, there are alternative treatments available for bladder cancer patients, especially for those who are unable to undergo surgery or wish to explore non-surgical options. These alternative treatment options can be used as standalone therapies or in conjunction with TURBT, depending on the individual needs and preferences of the patient.

Radiation Therapy:

Radiation therapy is a non-surgical treatment for bladder cancer that uses high-energy beams to target and destroy cancer cells. It can be delivered externally using a machine called a linear accelerator or internally using radioactive materials placed directly in the bladder. Radiation therapy is often used after TURBT to eliminate any remaining cancer cells and reduce the risk of recurrence.

Chemotherapy:

Chemotherapy involves the use of drugs to kill cancer cells throughout the body. It can be administered orally or intravenously and may be used before or after TURBT. Chemotherapy drugs can be effective in treating advanced or metastatic bladder cancer, as well as preventing the spread of cancer cells.

Immunotherapy:

Immunotherapy is a type of treatment that helps the body’s immune system fight against cancer. It works by stimulating the immune system to recognize and attack cancer cells. Immunotherapy drugs, such as checkpoint inhibitors, are now being used in the treatment of bladder cancer and have shown promising results.

Targeted Therapy:

Targeted therapy is a treatment approach that specifically targets the abnormalities present in cancer cells. These therapies work by blocking the signals that cancer cells need to divide and grow. Targeted therapy can be used in combination with other treatments, including TURBT, to enhance the effectiveness of the overall treatment plan.

Bladder cancer patients need to consult with their healthcare provider to determine the most appropriate treatment options for their specific case. Each alternative treatment option has its benefits and considerations, and the choice may depend on factors such as the stage and grade of the cancer, the overall health of the patient, and individual treatment goals.

Support and Resources for Bladder Cancer Patients

Receiving a bladder cancer diagnosis can be a challenging and overwhelming experience. However, there are numerous support networks, organizations, and resources available to provide assistance and guidance to bladder cancer patients and their loved ones.

One vital aspect of coping with bladder cancer is accessing emotional support. Dealing with a cancer diagnosis can have a significant emotional impact, and having a network of understanding individuals can be invaluable. Support groups, both in-person and online, offer a platform for patients to connect with others who have similar experiences. These groups provide a safe space to share thoughts, fears, and victories, fostering a sense of community and understanding.

Bladder cancer patients also benefit from educational resources that offer in-depth information related to their condition. Organizations such as the American Cancer Society and the Bladder Cancer Advocacy Network provide comprehensive educational materials, including brochures, websites, and videos, which cover topics ranging from treatment options to coping strategies. These resources empower patients to make informed decisions about their care and improve their overall well-being.

Practical assistance is another essential component of bladder cancer support. Many organizations offer programs that connect patients with services and resources to help them navigate their cancer journey. Support may include assistance with transportation to medical appointments, financial aid for treatment-related expenses, and guidance in accessing appropriate healthcare professionals and facilities.

Here is a list of some reputable organizations that provide support and resources for bladder cancer patients:

• American Cancer Society – www.cancer.org
• Bladder Cancer Advocacy Network – www.bcan.org
• Bladder Cancer Canada – www.bladdercancercanada.org
• The Urology Care Foundation – www.urologyhealth.org

Resources for Bladder Cancer Support

Organization	Website
American Cancer Society	www.cancer.org
Bladder Cancer Advocacy Network	www.bcan.org
Bladder Cancer Canada	www.bladdercancercanada.org
The Urology Care Foundation	www.urologyhealth.org

By utilizing these support networks, organizations, and resources, bladder cancer patients can find the help they need to navigate their cancer journey effectively. Whether it’s emotional support, educational materials, or practical assistance, these resources empower patients to face the challenges of bladder cancer with resilience and hope.

Conclusion

In conclusion, transurethral resection of bladder tumors (TURBT) is a highly effective and minimally invasive procedure for the treatment of bladder cancer. Throughout this article, we have discussed the various aspects of TURBT, including its benefits, the procedure itself, and the recovery process.

TURBT offers numerous advantages, such as the ability to remove bladder tumors without the need for open surgery, reduced hospital stays, and faster recovery times. It plays a crucial role in the diagnosis, treatment, and management of bladder cancer, particularly in early-stage and non-muscle invasive cases.

By utilizing advanced instruments and techniques, TURBT allows for precise tumor removal while minimizing damage to healthy bladder tissue. It is complemented by comprehensive follow-up care and monitoring to detect any signs of recurrence or new tumors. In cases where adjuvant treatments are necessary, TURBT can be combined with other therapies to optimize outcomes and improve long-term prognosis.

Patients undergoing TURBT should work closely with their healthcare team to ensure proper preparation, adherence to post-operative care instructions, and regular follow-up appointments. By taking these steps, individuals can maximize the success of their treatment and enhance their overall quality of life.

FAQ

What is transurethral resection of bladder tumor (TURBT)?

Transurethral resection of bladder tumor (TURBT) is a surgical procedure used to remove cancerous tumors from the bladder. It is a minimally invasive technique that involves using a resectoscope to remove the tumor through the urethra.

How is TURBT performed?

TURBT is performed using a specialized instrument called a resectoscope. The resectoscope is inserted through the urethra and guided to the bladder. The tumor is then removed using a wire loop or laser, and the area is cauterized to control bleeding.

What are the benefits of TURBT?

TURBT offers several benefits for bladder cancer patients. It is a minimally invasive procedure that allows for the removal of cancerous tumors without the need for open surgery. It has a shorter recovery time compared to traditional surgery and can help preserve bladder function.

How do I prepare for TURBT?

To prepare for TURBT, you may need to undergo medical evaluations and tests to assess your overall health and bladder condition. Your healthcare provider will provide specific instructions on medication usage, dietary restrictions, and any lifestyle changes that may be necessary.

What are the potential risks and complications of TURBT?

Like any surgical procedure, TURBT carries some risks and potential complications. These can include bleeding, infection, bladder perforation, and scarring. Your healthcare provider will discuss these risks with you and take steps to minimize them during the procedure.

What is the recovery process like after TURBT?

The recovery process after TURBT can vary depending on individual factors, such as the extent of the procedure and overall health. You may experience some discomfort and urinary symptoms in the days following surgery. Your healthcare provider will guide pain management, bladder care, and when you can resume normal activities.

Will I need follow-up care after TURBT?

Yes, follow-up care is essential after TURBT. Regular monitoring and surveillance are important to detect any recurrence or new tumors. Your healthcare provider may recommend periodic cystoscopies, imaging tests, and urine tests to ensure early detection and appropriate management.

Are there alternative treatment options for bladder cancer?

Yes, there are alternative treatment options for bladder cancer. These can include radiation therapy, chemotherapy, immunotherapy, and targeted therapy. They may be used alone or in combination with TURBT, depending on factors such as the stage and grade of the cancer.

Where can I find support and resources for bladder cancer?

There are various support networks, organizations, and resources available to bladder cancer patients and their families. These can provide emotional support, educational materials, and practical assistance. Your healthcare provider can provide recommendations or referrals to relevant resources.

In this article, we will explore whether stage 3B lung cancer can go into remission. We will explore the various treatment options available, discuss the survival rates associated with this stage of lung cancer, and examine the factors that can influence the chances of achieving remission.

Key Takeaways:

• Stage 3B lung cancer refers to cancer that has spread to nearby lymph nodes or other structures in the chest.
• Remission is possible for some patients with stage 3B lung cancer, but it depends on various factors.
• Treatment options for stage 3B lung cancer may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.
• Survival rates for stage 3B lung cancer can vary, with five-year survival rates ranging from 15% to 35%.
• Factors such as age, overall health, and response to treatment can influence the chances of achieving remission.

Understanding Stage 3B Lung Cancer

Stage 3B lung cancer is an advanced stage of the disease that typically indicates the spread of cancer cells to nearby lymph nodes or structures. Understanding the prognosis, spread, lymph node involvement, and symptoms associated with this stage is crucial for patients and their healthcare teams.

Prognosis and Spread

The prognosis for stage 3B lung cancer varies depending on individual factors such as overall health, age, and response to treatment. The five-year survival rate for stage 3B lung cancer is generally lower compared to earlier stages, as the cancer has spread beyond the lungs.

Stage 3B lung cancer often involves the spread of cancer cells to nearby lymph nodes. The lymph nodes play a crucial role in the body’s immune system, and their involvement in cancer indicates a higher stage of the disease. The spread to lymph nodes can impact treatment options and prognosis.

Symptoms

• Persistent cough or hoarseness
• Shortness of breath
• Chest pain
• Coughing up blood
• Wheezing
• Frequent respiratory infections
• Unexplained weight loss

These symptoms may not be specific to stage 3B lung cancer and can also be present in other respiratory conditions. It is important to consult a healthcare professional for a proper diagnosis if these symptoms persist.

Stage	Survival Rate
Stage 3B	Varies depending on individual factors, typically lower compared to earlier stages
Stage 3B with lymph node involvement	Lower than stage 3B without lymph node involvement

Treatment Options for Stage 3B Lung Cancer

When it comes to stage 3B lung cancer, there are several treatment options available. These options aim to target and destroy cancer cells, alleviate symptoms, and improve overall survival rates. The treatment plan for each patient may vary depending on factors such as the individual’s overall health, specific tumor characteristics, and personal preferences.

Surgery

Surgery is often considered for stage 3B lung cancer if the tumor is localized and has not spread extensively. The goal of surgery is to remove the tumor and nearby lymph nodes. It may involve a lobectomy (removal of a lobe of the lung), pneumonectomy (removal of an entire lung), or wedge resection (removal of a small portion of the lung).

Radiation Therapy

Radiation therapy is a common treatment approach for stage 3B lung cancer. It involves using high-energy beams to target and kill cancer cells. Radiation therapy may be given externally, using a machine that directs radiation to the tumor, or internally, by placing radioactive material near the tumor. This treatment option aims to shrink tumors, provide symptom relief, and improve overall survival rates.

Chemotherapy

Chemotherapy drugs are often used in combination with other treatments for stage 3B lung cancer. These drugs are designed to kill cancer cells throughout the body. Chemotherapy may be administered intravenously, orally, or directly into the lung. It can help shrink tumors, control the spread of cancer, and improve symptoms and overall survival rates.

Targeted Therapy

Targeted therapy is a newer approach in the treatment of stage 3B lung cancer. This treatment option involves using drugs that specifically target certain genetic mutations or proteins present in cancer cells. By targeting these specific abnormalities, targeted therapy aims to inhibit the growth and spread of cancer cells while minimizing damage to healthy cells.

Immunotherapy

Immunotherapy is another innovative treatment option for stage 3B lung cancer. It works by boosting the body’s immune system to recognize and attack cancer cells. Immunotherapy drugs, such as checkpoint inhibitors, aim to block proteins that prevent immune cells from attacking cancer cells. This treatment approach has shown promising results in improving overall survival rates and may be used alone or in combination with other treatments.

Comparison of Treatment Options

Treatment Option	Purpose	Potential Benefits	Potential Drawbacks
Surgery	Remove tumor and lymph nodes	– Potential cure – Localized tumor removal	– May not be feasible in advanced cases – Surgical risks
Radiation Therapy	Kill cancer cells, shrink tumors	– Symptom relief – Improved survival rates	– Potential side effects – Limited effectiveness in advanced cases
Chemotherapy	Kill cancer cells throughout the body	– Shrink tumors – Control the spread of cancer	– Side effects – May not be curative
Targeted Therapy	Inhibit the growth of cancer cells	– Target specific genetic mutations or proteins – Limited impact on healthy cells	– Limited effectiveness in certain cases – Potential side effects
Immunotherapy	Boost the immune system to attack cancer cells	– Improved overall survival rates – Potential long-term response	– Potential side effects – Limited effectiveness in certain cases

Combination Therapy for Stage 3B Lung Cancer

Combination therapy is a multifaceted approach to treating stage 3B lung cancer. It involves the simultaneous or sequential use of different treatment modalities to maximize the chances of remission and improve patient outcomes.

Concurrent Chemoradiation

Concurrent chemoradiation is a common form of combination therapy for stage 3B lung cancer. It involves the administration of chemotherapy drugs alongside radiation therapy. This dual approach targets both the primary tumor and any potential metastases, increasing the effectiveness of treatment.

Chemotherapy drugs used in concurrent chemoradiation may include platinum-based agents, such as cisplatin or carboplatin, combined with other medications like etoposide or docetaxel. These drugs work by disrupting the growth and division of cancer cells, making them more susceptible to the damaging effects of radiation therapy.

Concurrent chemoradiation has demonstrated improved local control of the tumor, increased survival rates, and higher rates of remission compared to radiation therapy alone. The combined approach allows for a more comprehensive attack on the cancer, targeting both the primary tumor and any potential microscopic spread.

Sequential Therapy

In sequential therapy, different treatment modalities are used one after the other, rather than simultaneously. This approach allows for a more tailored treatment regimen, taking into account the individual patient’s response to each therapy.

An example of sequential therapy for stage 3B lung cancer involves starting with chemotherapy followed by surgery or radiation therapy. The purpose of this approach is to first reduce the size of the tumor and eradicate any distant metastases through chemotherapy. Subsequently, surgery or radiation therapy can be employed to remove the remaining localized cancer cells.

Sequential therapy offers the advantage of allowing the healthcare team to assess the tumor response to chemotherapy and make treatment adjustments accordingly. This individualized treatment approach may improve the overall effectiveness of therapy and increase the chances of remission.

The Rationale and Impact

The rationale behind combination therapy lies in its ability to target the cancer from multiple angles and overcome potential resistance mechanisms. By utilizing different treatment modalities, combination therapy can enhance the effectiveness of treatment, potentially leading to deeper remission and improved patient outcomes.

The impact of combination therapy on remission rates for stage 3B lung cancer has been significant. Studies have shown that concurrent chemoradiation and sequential therapy can lead to higher rates of remission compared to single-modality treatments. By attacking the cancer from multiple fronts, combination therapy tackles both local and distant tumor sites, increasing the likelihood of achieving a disease-free state.

In conclusion, combination therapy, including concurrent chemoradiation and sequential therapy, offers a promising approach to the treatment of stage 3B lung cancer. By utilizing different treatment modalities, combination therapy aims to maximize the chances of remission and improve patient outcomes.

Prognosis and Survival Rates for Stage 3B Lung Cancer

When it comes to stage 3B lung cancer, understanding the prognosis and survival rates is crucial for patients and their loved ones. The prognosis refers to the likely course of the disease, while the survival rates provide insight into the percentage of patients who survive for a specific period after diagnosis.

It is important to note that prognosis and survival rates can vary depending on several factors, including the individual’s overall health, age, and response to treatment. However, the five-year survival rate is often used as a standard measure to gauge the long-term outlook for patients with stage 3B lung cancer.

Five-Year Survival Rate

The five-year survival rate for stage 3B lung cancer refers to the percentage of patients who survive at least five years after being diagnosed. It is an important metric that can provide hope and guidance to patients, helping them understand their chances of long-term survival.

According to the American Cancer Society, the five-year survival rate for stage 3B lung cancer is approximately 5% to 15%. However, it is essential to remember that survival rates are based on data collected from a large number of patients over several years. Individual experiences may vary, and advancements in treatment options can significantly impact survival rates.

Factors Influencing Prognosis and Survival Rates

Several factors can influence the prognosis and survival rates for stage 3B lung cancer. These factors include:

• The stage of the cancer: Stage 3B lung cancer has already spread to nearby lymph nodes, which can affect the chances of long-term survival.
• The overall health of the patient: Patients with better overall health and fitness levels tend to have a higher chance of responding well to treatment and achieving better outcomes.
• The age of the patient: Younger patients often have a better chance of surviving long-term due to a stronger immune system and overall resilience.
• The response to treatment: The effectiveness of the chosen treatment plan and the patient’s response to it can significantly impact survival rates.

It is important to remember that each individual’s case is unique, and survival rates are just one factor to consider when discussing prognosis. A comprehensive evaluation by healthcare professionals is necessary to determine the best course of treatment and individual prognosis.

Treatment Option	Survival Rates
Surgery	Varies depending on the extent of the disease and the patient’s overall health
Radiation Therapy	Can improve survival rates when used alone or in combination with other treatments
Chemotherapy	May prolong survival and improve quality of life
Targeted Therapy	Can be effective in specific cases with genetic mutations
Immunotherapy	Has shown promise in improving survival rates for some patients

In conclusion, understanding the prognosis and survival rates for stage 3B lung cancer is essential for patients and their families. While the overall five-year survival rate is relatively low, it is important to consider that advancements in treatment options and individual factors can significantly impact outcomes. A personalized approach, considering all relevant factors, can help determine the best course of treatment and provide patients with hope for the future.

Factors Influencing Remission for Stage 3B Lung Cancer

In the journey to achieving remission for stage 3B lung cancer, several factors play a crucial role. These factors determine the likelihood of entering a state of remission, where cancer cells are no longer detectable in the body. While the overall prognosis for stage 3B lung cancer can be challenging, understanding these influential factors can provide valuable insights for patients and their healthcare providers.

Age: Age is a significant factor that can influence the chances of remission for stage 3B lung cancer. Multiple studies have suggested that younger patients tend to have better outcomes with more successful responses to treatment. This could be attributed to factors such as a stronger immune system and better overall health, enabling them to tolerate and respond to therapies more effectively.

Overall Health: The overall health of an individual also plays a critical role in determining the potential for remission. Patients with good general health, including adequate organ function and absence of other medical conditions, may have a higher chance of responding well to treatment and achieving remission.

Response to Treatment: The response to treatment is a key factor that impacts the likelihood of achieving remission. Different treatment modalities, such as surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, can be tailored to individual patients based on their specific cancer characteristics. The effectiveness of these treatments, as measured by tumor response and reduction in cancerous cells, can significantly influence the chances of entering remission.

Understanding these factors provides valuable insights into the complex nature of stage 3B lung cancer and its potential for remission. By considering age, overall health, and response to treatment, healthcare providers can develop personalized treatment plans aimed at maximizing the chances of achieving remission and improving patients’ overall outcomes.

Clinical Trials and Experimental Treatments for Stage 3B Lung Cancer

In the management of stage 3B lung cancer, clinical trials and experimental treatments play a significant role. These trials offer patients access to innovative therapies that go beyond standard treatment options. While they may carry certain risks, they also hold the potential for breakthroughs in improving outcomes for individuals with this advanced stage of lung cancer.

Participating in a clinical trial for stage 3B lung cancer allows patients to contribute to the advancement of medical knowledge and potentially benefit from cutting-edge treatments. These trials can evaluate the effectiveness and safety of novel approaches, such as targeted therapies, immunotherapies, and combination treatments.

It’s important to note that clinical trials have specific eligibility criteria, and not all patients may qualify. Factors such as the patient’s overall health, previous treatments received, and specific genetic characteristics of the tumor may influence eligibility. Patients considering participation in a clinical trial should consult with their healthcare team to determine if they meet the criteria and discuss the potential benefits and risks.

To provide a comprehensive understanding of the role of clinical trials and experimental treatments, let’s explore some key points:

Potential Benefits of Clinical Trials for Stage 3B Lung Cancer

• Access to cutting-edge treatments: Clinical trials offer the opportunity to receive emerging therapies that may not be available through standard care options.
• Early access to promising drugs: Participating in a trial can provide early access to drugs that show potential for improved outcomes in stage 3B lung cancer.
• Contribution to medical progress: By joining a clinical trial, patients help researchers gather important data that can lead to advancements in the understanding and treatment of stage 3B lung cancer.

Risks and Considerations of Clinical Trials

• Potential side effects: Like any medical treatment, clinical trials carry the risk of side effects, some of which may be unknown.
• Unproven effectiveness: Experimental treatments may not yet have sufficient evidence to support their effectiveness in treating stage 3B lung cancer.
• Additional time and commitment: Participation in a clinical trial may require more frequent visits to the healthcare provider and additional tests or procedures.

It’s crucial for patients to carefully weigh the benefits and risks of clinical trials alongside their healthcare team to make an informed decision. Clinical trial information can be obtained through various sources, including cancer centers, research institutions, and online databases, which provide details on ongoing trials and eligibility criteria.

Experimental treatments within clinical trials offer the potential for advancements in treating stage 3B lung cancer. While risks and considerations should be taken into account, these trials pave the way for innovative approaches that may reshape the landscape of lung cancer treatment in the future.

Clinical Trials	Experimental Treatments
Provide access to cutting-edge treatments	Potentially improve outcomes for stage 3B lung cancer patients
Evaluate the safety and effectiveness of novel approaches	Offer the opportunity for early access to promising drugs
Contribute to medical progress and knowledge	Shape the future of lung cancer treatment

Coping Strategies and Support for Stage 3B Lung Cancer Patients

Receiving a diagnosis of stage 3B lung cancer can be overwhelming and emotionally challenging. Along with medical treatments, patients must have coping strategies and a strong support system in place to navigate through their cancer journey.

1. Counseling:

Counseling can provide valuable emotional support and guidance for stage 3B lung cancer patients. Professional counselors or therapists can help individuals cope with the emotional and psychological impact of their diagnosis, manage stress and anxiety, and develop healthy coping mechanisms. They can also assist in addressing any concerns or fears related to treatment and long-term prognosis.

2. Support Groups:

Joining support groups can offer a sense of community and understanding for stage 3B lung cancer patients. Interacting with others who are going through similar experiences can provide emotional support, practical advice, and a safe space to share thoughts and feelings. Support groups can be in-person or online, allowing patients to connect with individuals from various locations.

3. Online Resources:

Several online resources are available to support stage 3B lung cancer patients and their families. Websites, forums, and social media groups dedicated to lung cancer provide access to educational materials, survivor stories, and opportunities for interaction and support. It is important to approach online resources with caution and verify the credibility of the information shared.

4. Family and Friends:

The support of family and friends plays a crucial role in helping stage 3B lung cancer patients cope with their diagnosis. Loved ones can provide emotional support, assist with daily tasks, accompany patients to medical appointments, and be a source of comfort and encouragement throughout the treatment process.

Stage 3B lung cancer patients need to explore and utilize coping strategies and support resources that best suit their individual needs. Whether it is counseling, support groups, online resources, or the support of loved ones, these avenues can provide the much-needed strength and resilience required to navigate through the challenges of living with stage 3B lung cancer.

Lifestyle Modifications and Prevention

When it comes to stage 3B lung cancer, lifestyle modifications, and prevention strategies play a crucial role in improving outcomes and reducing the risk of recurrence. Making positive changes in habits and adopting a healthy lifestyle can make a significant difference in the overall well-being of individuals with this advanced stage of lung cancer.

Tobacco Cessation

Quitting smoking is essential for both preventing and managing stage 3B lung cancer. Tobacco smoke contains numerous harmful chemicals that can damage the lungs and increase the risk of developing cancer. By quitting smoking, individuals can reduce their risk of recurrence and improve their overall lung health.

Healthy Diet

Adopting a healthy diet is another vital aspect of lifestyle modification for stage 3B lung cancer. Consuming a balanced diet that is rich in fruits, vegetables, whole grains, and lean proteins can provide the body with the necessary nutrients to support overall health and recovery. Additionally, it is important to limit the consumption of processed foods, sugary beverages, and high-fat foods.

Exercise

Incorporating regular exercise into daily routines can greatly benefit individuals with stage 3B lung cancer. Physical activity not only improves overall fitness and strength but also boosts the immune system, reduces fatigue, and enhances overall well-being. Engaging in activities such as walking, swimming, or yoga can help individuals maintain a healthy weight, manage stress, and improve their quality of life.

By adopting these lifestyle modifications and prevention strategies, individuals with stage 3B lung cancer can significantly improve their chances of remission, enhance their overall well-being, and reduce the risk of recurrence. These changes, coupled with appropriate medical treatments, can empower individuals to actively participate in their journey towards better health and improved outcomes.

The Future of Stage 3B Lung Cancer Treatment

As medical research continues to advance, the future of stage 3B lung cancer treatment shows promise with emerging therapies and the development of personalized medicine. These advancements offer hope for improved outcomes and targeted approaches to combat this aggressive form of lung cancer.

One of the key areas of focus in the future of stage 3B lung cancer treatment is the exploration of emerging therapies. Researchers are investigating novel treatment modalities, such as targeted therapies and immunotherapies, which show potential in selectively targeting cancer cells while minimizing damage to healthy tissues. The aim is to provide patients with more effective and less invasive treatment options.

Moreover, the concept of personalized medicine is gaining traction in the field of stage 3B lung cancer treatment. By analyzing a patient’s unique genetic makeup and tumor characteristics, healthcare professionals can tailor treatment plans to individual needs, increasing the chances of successful outcomes. This personalized approach may involve the use of biomarkers to identify specific genetic mutations and guide the selection of targeted therapies that are most likely to be effective.

Looking ahead, the future of stage 3B lung cancer treatment holds great potential. As scientific knowledge and technological advancements continue to expand, there is growing optimism that emerging therapies and personalized medicine will revolutionize the approach to managing this challenging disease, offering new hope to patients and their families.

FAQ

Can stage 3B lung cancer go into remission?

Yes, stage 3B lung cancer can go into remission. Achieving remission depends on various factors such as the specific characteristics of the cancer, the individual’s overall health, and the effectiveness of the chosen treatment options.

What are the treatment options for stage 3B lung cancer?

The treatment options for stage 3B lung cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. The choice of treatment depends on the individual’s specific circumstances and may involve a combination of these approaches.

What is the prognosis and survival rate for stage 3B lung cancer?

The prognosis and survival rates for stage 3B lung cancer vary depending on several factors, including the stage of cancer, overall health, and response to treatment. The five-year survival rate for stage 3B lung cancer ranges from approximately 15% to 30%.

How can lifestyle modifications and prevention strategies help in managing stage 3B lung cancer?

Lifestyle modifications such as tobacco cessation, adopting a healthy diet, and engaging in regular exercise can help in managing stage 3B lung cancer. These strategies promote overall well-being and may improve treatment outcomes.

Are there clinical trials and experimental treatments available for stage 3B lung cancer?

Yes, there are clinical trials and experimental treatments available for stage 3B lung cancer. These trials aim to explore new treatment approaches and therapies that may further improve outcomes for patients with this stage of lung cancer.

What factors influence the chances of achieving remission for stage 3B lung cancer?

Several factors can influence the chances of achieving remission for stage 3B lung cancer, including age, overall health, and response to treatment. Individuals need to work closely with their healthcare team to develop a personalized treatment plan.

How can coping strategies and support benefit stage 3B lung cancer patients?

Coping strategies and support, such as counseling and participation in support groups, can benefit stage 3B lung cancer patients. These resources provide emotional support, information, and assistance in navigating through the challenges of a cancer diagnosis.

What is combination therapy for stage 3B lung cancer?

Combination therapy for stage 3B lung cancer involves the use of multiple treatment modalities, such as concurrent chemoradiation and sequential therapy. This approach aims to enhance the effectiveness of treatment and improve the chances of achieving remission.

How does stage 3B lung cancer spread to lymph nodes?

Stage 3B lung cancer can spread to lymph nodes when cancer cells break away from the primary tumor and travel through the lymphatic system. Lymph nodes are an important part of the body’s immune system and are commonly involved in the spread of lung cancer.

What are the common symptoms of stage 3B lung cancer?

Common symptoms of stage 3B lung cancer may include persistent cough, shortness of breath, chest pain, recurrent respiratory infections, fatigue, and unintentional weight loss. It is important to consult a healthcare professional if any of these symptoms persist or worsen.

What is the future of stage 3B lung cancer treatment?

The future of stage 3B lung cancer treatment holds promise with emerging therapies and the potential of personalized medicine. Ongoing research aims to improve treatment outcomes, enhance targeted therapies, and develop innovative approaches to managing this stage of lung cancer.